<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <title>Cancer Metabolism might be fought by many things – such as vitamin D</title>
    <link rel="stylesheet" href="/css/main.css?v=1742566338">
    <link rel="stylesheet" href="/css/pagination.css?v=1742566338">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <script src="https://unpkg.com/lunr/lunr.js"></script>
    <script src="/js/search.js?v=1742566338"></script>
</head>
<body>
    <div class="container">
        <div class="sidebar">
            <h2>Search</h2>
            <div class="search-container">
                <input type="text" id="search-input" placeholder="Loading search index..." disabled>
                <div id="search-status" class="search-status">Loading search index...</div>
                <div id="suggestions" class="search-suggestions"></div>
            </div>
            <ul id="search-results"></ul>
            
            <h2>Categories</h2>
            <ul data-spa-nav>
                
                <li><a href="/categories/about-d---introduction/">About D - Introduction (3)</a></li>
                
                <li><a href="/categories/about-d---more-info./">About D - More Info. (3)</a></li>
                
                <li><a href="/categories/adhd/">ADHD (5)</a></li>
                
                <li><a href="/categories/admin-only/">Admin Only (5)</a></li>
                
                <li><a href="/categories/ai/">AI (31)</a></li>
                
                <li><a href="/categories/antibiotics-probiotics/">Antibiotics, Probiotics (4)</a></li>
                
                <li><a href="/categories/associations/">Associations (1)</a></li>
                
                <li><a href="/categories/autism/">Autism (10)</a></li>
                
                <li><a href="/categories/autoimmune/">Autoimmune (9)</a></li>
                
                <li><a href="/categories/back-pain/">Back Pain (3)</a></li>
                
                <li><a href="/categories/better-than-daily/">Better Than Daily (6)</a></li>
                
                <li><a href="/categories/bipolar/">Bipolar (1)</a></li>
                
                <li><a href="/categories/bone---health/">Bone - Health (12)</a></li>
                
                <li><a href="/categories/books-videos-on-vitamin-d/">Books, Videos on Vitamin D (28)</a></li>
                
                <li><a href="/categories/breathing/">Breathing (16)</a></li>
                
                <li><a href="/categories/calcidiol/">Calcidiol (2)</a></li>
                
                <li><a href="/categories/cancer/">Cancer (30)</a></li>
                
                <li><a href="/categories/cancer---after-diagnosis/">Cancer - After Diagnosis (12)</a></li>
                
                <li><a href="/categories/cancer---bladder/">Cancer - Bladder (2)</a></li>
                
                <li><a href="/categories/cancer---breast/">Cancer - Breast (13)</a></li>
                
                <li><a href="/categories/cancer---colon/">Cancer - Colon (8)</a></li>
                
                <li><a href="/categories/cancer---leukemia/">Cancer - Leukemia (1)</a></li>
                
                <li><a href="/categories/cancer---liver/">Cancer - Liver (1)</a></li>
                
                <li><a href="/categories/cancer---lung/">Cancer - Lung (1)</a></li>
                
                <li><a href="/categories/cancer---lymphoma/">Cancer - Lymphoma (1)</a></li>
                
                <li><a href="/categories/cancer---other/">Cancer - Other (7)</a></li>
                
                <li><a href="/categories/cancer---ovarian/">Cancer - Ovarian (2)</a></li>
                
                <li><a href="/categories/cancer---pancreatic/">Cancer - Pancreatic (1)</a></li>
                
                <li><a href="/categories/cancer---prostate/">Cancer - Prostate (4)</a></li>
                
                <li><a href="/categories/cancer---skin/">Cancer - Skin (5)</a></li>
                
                <li><a href="/categories/cardiovascular/">Cardiovascular (35)</a></li>
                
                <li><a href="/categories/category/">Category (1)</a></li>
                
                <li><a href="/categories/cholesterol/">Cholesterol (1)</a></li>
                
                <li><a href="/categories/cognitive/">Cognitive (34)</a></li>
                
                <li><a href="/categories/conference/">Conference (1)</a></li>
                
                <li><a href="/categories/consensus/">Consensus (3)</a></li>
                
                <li><a href="/categories/cost-savings-with-vitamin-d/">Cost Savings With Vitamin D (10)</a></li>
                
                <li><a href="/categories/curcumin/">Curcumin (1)</a></li>
                
                <li><a href="/categories/cyp27b1/">CYP27B1 (6)</a></li>
                
                <li><a href="/categories/cystic-fibrosis/">Cystic Fibrosis (2)</a></li>
                
                <li><a href="/categories/deficiency-of-vitamin-d/">Deficiency of Vitamin D (28)</a></li>
                
                <li><a href="/categories/dental/">Dental (18)</a></li>
                
                <li><a href="/categories/depression/">Depression (17)</a></li>
                
                <li><a href="/categories/diabetes/">Diabetes (23)</a></li>
                
                <li><a href="/categories/epilepsy/">Epilepsy (1)</a></li>
                
                <li><a href="/categories/evidence-for-d/">Evidence for D (7)</a></li>
                
                <li><a href="/categories/falls-and-fractures/">Falls and Fractures (21)</a></li>
                
                <li><a href="/categories/fertility-and-sperm/">Fertility and Sperm (10)</a></li>
                
                <li><a href="/categories/food-sources-for-vitamin-d/">Food Sources for Vitamin D (2)</a></li>
                
                <li><a href="/categories/forms-of-vitamin-d/">Forms of Vitamin D (8)</a></li>
                
                <li><a href="/categories/fortification-with-vitamin-d/">Fortification With Vitamin D (8)</a></li>
                
                <li><a href="/categories/genetics/">Genetics (19)</a></li>
                
                <li><a href="/categories/greger/">Greger (4)</a></li>
                
                <li><a href="/categories/gut/">Gut (13)</a></li>
                
                <li><a href="/categories/headache/">Headache (4)</a></li>
                
                <li><a href="/categories/health/">Health (14)</a></li>
                
                <li><a href="/categories/high-risk/">High Risk (3)</a></li>
                
                <li><a href="/categories/high-dose/">High-Dose (9)</a></li>
                
                <li><a href="/categories/how-much-vitamin-d/">How Much Vitamin D (4)</a></li>
                
                <li><a href="/categories/how-when-to-take-vit.-d/">How, When to Take Vit. D (4)</a></li>
                
                <li><a href="/categories/hypertension/">Hypertension (6)</a></li>
                
                <li><a href="/categories/immunity/">Immunity (13)</a></li>
                
                <li><a href="/categories/increased-use-of-d/">Increased Use of D (2)</a></li>
                
                <li><a href="/categories/infant-child/">Infant-Child (64)</a></li>
                
                <li><a href="/categories/inflammation/">Inflammation (12)</a></li>
                
                <li><a href="/categories/interactions-with-vitamin-d/">Interactions With Vitamin D (11)</a></li>
                
                <li><a href="/categories/intervention/">Intervention (39)</a></li>
                
                <li><a href="/categories/intervention---non-daily/">Intervention - Non Daily (21)</a></li>
                
                <li><a href="/categories/iodine/">Iodine (1)</a></li>
                
                <li><a href="/categories/kidney/">Kidney (7)</a></li>
                
                <li><a href="/categories/liver/">Liver (3)</a></li>
                
                <li><a href="/categories/loading-dose-for-vitamin-d/">Loading Dose for Vitamin D (9)</a></li>
                
                <li><a href="/categories/lupus/">Lupus (3)</a></li>
                
                <li><a href="/categories/meta-analysis-of-vitamin-d/">Meta-Analysis of Vitamin D (52)</a></li>
                
                <li><a href="/categories/metabolic-syndrome/">Metabolic Syndrome (10)</a></li>
                
                <li><a href="/categories/microbiome/">Microbiome (6)</a></li>
                
                <li><a href="/categories/middle-east/">Middle East (2)</a></li>
                
                <li><a href="/categories/mortality-and-d/">Mortality and D (23)</a></li>
                
                <li><a href="/categories/multiple-sclerosis/">Multiple Sclerosis (21)</a></li>
                
                <li><a href="/categories/noontime-sun-and-d/">Noontime Sun and D (11)</a></li>
                
                <li><a href="/categories/obesity/">Obesity (29)</a></li>
                
                <li><a href="/categories/off-topic/">Off Topic (5)</a></li>
                
                <li><a href="/categories/optimum/">Optimum (4)</a></li>
                
                <li><a href="/categories/orient/">Orient (4)</a></li>
                
                <li><a href="/categories/osteoarthritis/">Osteoarthritis (1)</a></li>
                
                <li><a href="/categories/osteoporosis/">Osteoporosis (13)</a></li>
                
                <li><a href="/categories/overview-for-doctors/">Overview for Doctors (1)</a></li>
                
                <li><a href="/categories/pain---chronic/">Pain - Chronic (8)</a></li>
                
                <li><a href="/categories/parkinson/">Parkinson (14)</a></li>
                
                <li><a href="/categories/patent/">Patent (1)</a></li>
                
                <li><a href="/categories/predict-vitamin-d/">Predict Vitamin D (3)</a></li>
                
                <li><a href="/categories/pregnancy/">Pregnancy (48)</a></li>
                
                <li><a href="/categories/psoriasis/">Psoriasis (5)</a></li>
                
                <li><a href="/categories/quality-of-life/">Quality of Life (3)</a></li>
                
                <li><a href="/categories/resveratrol/">Resveratrol (2)</a></li>
                
                <li><a href="/categories/rheumatoid-arthritis/">Rheumatoid Arthritis (6)</a></li>
                
                <li><a href="/categories/rickets/">Rickets (1)</a></li>
                
                <li><a href="/categories/season-of-birth/">Season of Birth (1)</a></li>
                
                <li><a href="/categories/seniors/">Seniors (27)</a></li>
                
                <li><a href="/categories/shut-in/">Shut-In (2)</a></li>
                
                <li><a href="/categories/skin/">Skin (8)</a></li>
                
                <li><a href="/categories/skin---dark/">Skin - Dark (9)</a></li>
                
                <li><a href="/categories/sleep/">Sleep (7)</a></li>
                
                <li><a href="/categories/sports-and-vitamin-d/">Sports and Vitamin D (10)</a></li>
                
                <li><a href="/categories/stroke/">Stroke (12)</a></li>
                
                <li><a href="/categories/supplement/">Supplement (4)</a></li>
                
                <li><a href="/categories/technical-d/">Technical D (1)</a></li>
                
                <li><a href="/categories/tests-for-vitamin-d/">Tests for Vitamin D (3)</a></li>
                
                <li><a href="/categories/thyroid-and-parathyroid/">Thyroid and Parathyroid (1)</a></li>
                
                <li><a href="/categories/top-news/">Top News (7)</a></li>
                
                <li><a href="/categories/toxicity-of-vitamin-d/">Toxicity of Vitamin D (1)</a></li>
                
                <li><a href="/categories/trauma-and-surgery/">Trauma and Surgery (15)</a></li>
                
                <li><a href="/categories/tuberculosis/">Tuberculosis (3)</a></li>
                
                <li><a href="/categories/uv-and-vitamin-d/">UV and Vitamin D (14)</a></li>
                
                <li><a href="/categories/veterinary-and-vitamin-d/">Veterinary and Vitamin D (4)</a></li>
                
                <li><a href="/categories/virus/">Virus (160)</a></li>
                
                <li><a href="/categories/vision/">Vision (14)</a></li>
                
                <li><a href="/categories/vit-d-binding-protein/">Vit D Binding Protein (8)</a></li>
                
                <li><a href="/categories/vitamin-b12/">Vitamin B12 (5)</a></li>
                
                <li><a href="/categories/vitamin-c/">Vitamin C (4)</a></li>
                
                <li><a href="/categories/vitamin-d-and-boron/">Vitamin D and Boron (6)</a></li>
                
                <li><a href="/categories/vitamin-d-and-calcium/">Vitamin D and Calcium (6)</a></li>
                
                <li><a href="/categories/vitamin-d-and-iron/">Vitamin D and Iron (3)</a></li>
                
                <li><a href="/categories/vitamin-d-and-magnesium/">Vitamin D and Magnesium (22)</a></li>
                
                <li><a href="/categories/vitamin-d-and-omega-3/">Vitamin D and Omega-3 (18)</a></li>
                
                <li><a href="/categories/vitamin-d-and-vitamin-a/">Vitamin D and Vitamin A (1)</a></li>
                
                <li><a href="/categories/vitamin-d-and-vitamin-k/">Vitamin D and Vitamin K (8)</a></li>
                
                <li><a href="/categories/vitamin-d-far-from-equator/">Vitamin D Far From Equator (4)</a></li>
                
                <li><a href="/categories/vitamin-d-in-australia-and-new-zealand/">Vitamin D in Australia and New Zealand (2)</a></li>
                
                <li><a href="/categories/vitamin-d-in-canada/">Vitamin D in Canada (2)</a></li>
                
                <li><a href="/categories/vitamin-d-in-europe/">Vitamin D in Europe (4)</a></li>
                
                <li><a href="/categories/vitamin-d-receptor/">Vitamin D Receptor (39)</a></li>
                
                <li><a href="/categories/vitamin-d3-instead-of-d2/">Vitamin D3 Instead of D2 (1)</a></li>
                
                <li><a href="/categories/women/">Women (13)</a></li>
                
                <li><a href="/categories/youth/">Youth (8)</a></li>
                
                <li><a href="/categories/zinc/">Zinc (6)</a></li>
                
            </ul>
        </div>
        <div class="content" role="main">
            
    <article>
        <h1>Cancer Metabolism might be fought by many things – such as vitamin D</h1>
        <time>October 1, 2023</time>
        <!-- {maketoc Title=""} -->
<hr>
<h4 id="cancer-metabolism-as-a-therapeutic-target-and-review-of-interventions">Cancer Metabolism as a Therapeutic Target and Review of Interventions</h4>
<p>Nutrients 2023, 15, 4245. <a href="https://doi.org/10.3390/">https://doi.org/10.3390/</a> nu15194245</p>
<p>Matthew T. J. Halma 1,2 , Jack A. Tuszynski3,4,5 and Paul E. Marik ^*</p>
<p>Department of Physics and Astronomy, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands</p>
<p>EbMC Squared CIC, Bath BA2 4BL, UK</p>
<p>Department of Physics, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB T6G 2M9, Canada</p>
<p>Department of Data Science and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland</p>
<p>DIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, I-1029 Turin, Italy</p>
<p>Frontline COVID-19 Critical Care Alliance, Washington, DC 20036, USA * Correspondence: <a href="mailto:pmarik@flccc.net">pmarik@flccc.net</a></p>
<img src="/attachments/d3.mock.jpg" alt="image" width="800">
<p>Cancer is amenable to low-cost treatments, given that it has a significant metabolic com­ponent, which can be affected through diet and lifestyle change at minimal cost. The Warburg hypothesis states that cancer cells have an altered cell metabolism towards anaerobic glycolysis. Given this metabolic reprogramming in cancer cells, it is possible to target cancers metabolically by depriving them of glucose. In addition to dietary and lifestyle modifications which work on tumors metabolically, there are a panoply of nutritional supplements and repurposed drugs associated with cancer prevention and better treatment outcomes. These interventions and their evidentiary basis are covered in the latter half of this review to guide future cancer treatment.</p>
<h5 id="recommended-vitamin-d-extracted-from-pdf">Recommended: Vitamin D (Extracted from PDF)</h5>
<p>Vitamin D is synthesized in the human skin through the influence of UV B radiation and is then converted into the active form, 1,25-dihydroxyvitamin D3 (calcitriol), in the kidney <span>[323-325]</span>. 25-hydroxyvitamin D3 (25(OH)D3) is considered the best indicator of vitamin D status, with a level &gt; 30 ng/mL considered normal, 20-30 ng/mL considered insufficient, and &lt;20 ng/mL considered deficient <span>[324-326]</span>. Recent data suggest that a level &gt; 50 ng/mL is desirable, and, ideally, targeting a level between 55 and 90 ng/mL is preferable <span>[323,327-329]</span>. Adequate vitamin D supplementation is important to achieve optimal levels in patients with low vitamin D levels, and using 50,000 IU D3 capsules in divided doses over a few days is recommended <sup>[323,328,329]</sup> (Supplementary Table S1).</p>
<p>Vitamin D plays a critical role in various physiological pathways, including energy metabolism, immunity, and cellular growth <sup>[330]</sup>. It has pleiotropic functions and regulates over 1200 genes within the human genome, with a significant role in the modulation of the immune system <sup>[323,331,332]</sup>. Observational and randomized controlled studies indicate that a low vitamin D status is associated with higher mortality from conditions like cancer and cardiovascular disease <sup>[333,334]</sup>. Vitamin D deficiency increases the risk of breast, colon, prostate, and other cancers, while supplemental vitamin D intake has an inverse relationship with cancer risk <sup>[324,335]</sup>. Higher latitudes are associated with increased risk of vitamin D deficiency and various cancers, with vitamin D supplementation likely playing a crucial role in cancer prevention <sup>[324,336]</sup>. Achieving a vitamin D level of 80 ng/mL may reduce cancer incidence rates by 70% <sup>[337]</sup>.</p>
<p><strong>Mechanism</strong></p>
<p>Vitamin D exhibits diverse antineoplastic activity through various pathways. It binds to the vitamin D receptor and induces differentiation and apoptosis; it also inhibits cancer stem cells, proliferation, angiogenesis, and metastatic potential <sup>[338]</sup>. It promotes apoptosis of cancer cells, inhibits WNT-p catenin signaling, and has anti-inflammatory effects by downregulating nuclear factor-Kp and inhibiting cyclooxygenase expression <span>[339-341]</span>. Vitamin D also regulates cell cycle, growth factor pathways, and immune responses against tumor cells <sup>[337,342]</sup>. It triggers autophagic death, promotes cell differentiation, and exhibits anti-angiogenic effects <sup>[337,343,344]</sup>. These mechanisms collectively contribute to vitamin D&rsquo;s anticancer effects and may help reduce cancer incidence and mortality <sup>[336]</sup>.</p>
<p><strong>Clinical Evidence</strong></p>
<p>Multiple studies indicate that a significant proportion of cancer patients are vitamin D-deficient (level &lt; 20 ng/mL) and that higher plasma 25-hydroxyvitamin D levels are associated with improved survival in colorectal, breast, gastric, and lymphoma cancer patients <span>[334,338,345-351]</span>. Meta-analyses and clinical trials demonstrate that vitamin D supplementation may reduce cancer mortality and improve survival in cancer patients, especially when used in combination with chemotherapy <span>[352-358]</span>. SUNSHINE, a clinical trial on metastatic colorectal cancer patients, showed that “high-dose&quot; vitamin D3 (aiming for a level of &gt;50 ng/mL) combined with standard chemotherapy resulted in improved progression-free survival compared to standard-dose vitamin D3 <sup>[338]</sup>. Adequate vitamin D dosing aiming for a level between 55 and 90 ng/mL may have additional benefits in cancer patients <sup>[338]</sup>. Vitamin D supplementation is suggested to have additive or synergistic effects when combined with conventional chemotherapy <sup>[359,360]</sup>.</p>
<p><strong>Dosing Recommendation</strong></p>
<p>Vitamin D supplementation is likely beneficial for most types of cancers, especially breast, colorectal, gastric, esophageal, lung, and prostate cancer, lymphomas, and melanoma. Due to the severe vitamin D deficiency observed in most cancer patients, a high loading dose of vitamin D is recommended, followed by dose titration aiming for a level of &gt;50 ng/mL (target 55-90 ng/mL). Some types of cancer may require higher levels, up to 150 ng/mL, to halt growth and metastasis. Daily doses of 20,000 to 50,000 IU/day are suggested until the desired vitamin D level is reached. It is important to monitor vitamin D levels to ensure appropriate maintenance dosing, and daily dosing of vitamin D3 is preferred over large intermittent bolus dosing. Vitamin K2 (menaquinone (MK4/MK7)) and magnesium are recommended in conjunction with high vitamin D doses (&gt;8000 IU/day). Measuring parathyroid levels and calcium levels can help titrate the vitamin D dose according to the Coimbra Protocol <sup>[65,66]</sup>.</p>
<p><strong><a href="/attachments/d3.mock.pdf"><i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i>Download the PDF from VitaminDWiki </a></strong></p>
<h5 id="39-vitamin-d-references-of-520-references">39 Vitamin D references (of 520 references)</h5>
<ul>
<li>
<p>Wimalawansa, S.J. Physiological Basis for Using  <strong>Vitamin D</strong>  to Improve Health. Biomedicines 2023,11,1542. <span>[CrossRef]</span></p>
</li>
<li>
<p>Holick, M.F.  <strong>Vitamin D</strong>  Deficiency. N. Engl. J. Med. 2002, 357, 266-281. <span>[CrossRef]</span></p>
</li>
<li>
<p>Brandi, M.L. Indications on the use of  <strong>Vitamin D</strong>  and  <strong>Vitamin D</strong>  metabolites in clinical phenotypes. Clin. Cases Miner. Bone Metab. 2010, 7, 243-250.</p>
</li>
<li>
<p>Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, PJ. Prevalence of  <strong>Vitamin D</strong>  Insufficiency in an Adult Normal Population. Osteoporos. lnt. 1997, 7, 439-443. <span>[CrossRef]</span></p>
</li>
<li>
<p>Vieth, R. Why the optimal requirement for  <strong>Vitamin D</strong> 3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579. <span>[CrossRef]</span></p>
</li>
<li>
<p>Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients 2022,14, 2997. <span>[CrossRef]</span></p>
</li>
<li>
<p>Wimalawansa, S.J. Effective and practical ways to overcome  <strong>Vitamin D</strong>  deficiency. J. Fam. Med. Community Health 2021, 8,1185.</p>
</li>
<li>
<p>Carlberg, C.; Velleuer, E.  <strong>Vitamin D</strong>  and the risk for cancer: A molecular analysis. Biochem. Pharmacol. 2022,196,114735. <span>[CrossRef]</span></p>
</li>
<li>
<p>Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C.  <strong>Vitamin D</strong> : Modulator of the immune system. Curr. Opin. Pharmacol. 2010,10, 482-496. <span>[CrossRef]</span></p>
</li>
<li>
<p>Bartley, J.  <strong>Vitamin D</strong> : Emerging roles in infection and immunity. Expert Rev. Anti-lnfect. Ther. 2010, 8,1359-1369. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B.  <strong>Vitamin D</strong>  and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I.W.; O&rsquo;Neil, B.H.; Innocenti, F.  <strong>Vitamin D</strong>  status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol. 2015, 33, 3503. <span>[CrossRef]</span></p>
</li>
<li>
<p>Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J.  <strong>Vitamin D</strong>  and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN 2019, 30,170-184. <span>[CrossRef]</span></p>
</li>
<li>
<p>Zhang, Y.; Fang, F.; Tang, J.; Jia, L.; Feng, Y.; Xu, P.; Faramand, A. Association between  <strong>Vitamin D</strong>  supplementation and mortality: Systematic review and meta-analysis. BMJ 2019, 366, l4673. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Muñoz, A.; Grant, W.B.  <strong>Vitamin D</strong>  and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022, 14,1448. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Ng, K.; Nimeiri, H.S.; McCleary, N.J.; Abrams, T.A.; Yurgelun, M.B.; Cleary, J.M.; Rubinson, D.A.; Schrag, D.; Miksad, R.; Bullock, A.J. Effect of high-dose vs standard-dose  <strong>Vitamin D</strong> 3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA 2019, 321,1370-1379. <span>[CrossRef]</span></p>
</li>
<li>
<p>Díaz, G.D.; Paraskeva, C.; Thomas, M.G.; Binderup, L.; Hague, A. Apoptosis is induced by the active metabolite of  <strong>Vitamin D</strong> 3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res. 2000, 60, 2304-2312. <span>[PubMed]</span></p>
</li>
<li>
<p>Feldman, D.; Krishnan, A.V.; Swami, S.; Giovannucci, E.; Feldman, B.J. The role of  <strong>Vitamin D</strong>  in reducing cancer risk and progression. Nat. Rev. Cancer 2014,14, 342-357. <span>[CrossRef]</span></p>
</li>
<li>
<p>Mathieu, C.; Adorini, L. The coming of age of 1, 25-dihydroxy <strong>Vitamin D</strong> 3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8,174-179. <span>[CrossRef]</span></p>
</li>
<li>
<p>Yang, E.S.; Burnstein, K.L.  <strong>Vitamin D</strong>  inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278, 46862-46868. <span>[CrossRef]</span></p>
</li>
<li>
<p>Larriba, M.J.; García de Herreros, A.; Muñoz, A.  <strong>Vitamin D</strong>  and the epithelial to mesenchymal transition. Stem Cells lnt. 2016, 2016, 6213872. <span>[CrossRef]</span></p>
</li>
<li>
<p>Bernardi, R.J.; Johnson, C.S.; Modzelewski, R.A.; Trump, D.L. Antiproliferative effects of 1a, 25-dihydroxy <strong>Vitamin D</strong> 3 and  <strong>Vitamin D</strong>  analogs on tumor-derived endothelial cells. Endocrinology 2002,143, 2508-2514. <span>[CrossRef]</span></p>
</li>
<li>
<p>Ng, K.; Meyerhardt, J.A.; Wu, K.; Feskanich, D.; Hollis, B.W.; Giovannucci, E.L.; Fuchs, C.S. Circulating 25-hydroxy <strong>Vitamin D</strong>  levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 2984-2991. <span>[CrossRef]</span></p>
</li>
<li>
<p>Johansson, H.; Spadola, G.; Tosti, G.; Mandalà, M.; Minisini, A.M.; Queirolo, P.; Aristarco, V.; Baldini, F.; Cocorocchio, E.; Albertazzi, E.  <strong>Vitamin D</strong>  supplementation and disease-free survival in stage II melanoma: A randomized placebo controlled trial. Nutrients 2021,13,1931. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Yuan, C.; Sato, K.; Hollis, B.W.; Zhang, S.; Niedzwiecki, D.; Ou, F.-S.; Chang, I.W.; O&rsquo;Neil, B.H.; Innocenti, F.; Lenz, H.-J. Plasma 25-hydroxy <strong>Vitamin D</strong>  levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin. Cancer Res. 2019, 25,7497-7505. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Mezawa, H.; Sugiura, T.; Watanabe, M.; Norizoe, C.; Takahashi, D.; Shimojima, A.; Tamez, S.; Tsutsumi, Y.; Yanaga, K.; Urashima, M. Serum  <strong>Vitamin D</strong>  levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer 2010,10, 347. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma  <strong>Vitamin D</strong>  concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol. 2014, 32, 2430-2439. <span>[CrossRef]</span></p>
</li>
<li>
<p>Toriola, A.T.; Nguyen, N.; Scheitler-Ring, K.; Colditz, G.A. Circulating 25-hydroxy <strong>Vitamin D</strong>  levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol. Biomark. Prev. 2014, 23, 917-933. <span>[CrossRef]</span></p>
</li>
<li>
<p>Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxy <strong>Vitamin D</strong>  and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012, 23, 363-370. <span>[CrossRef]</span></p>
</li>
<li>
<p>Chen, Q.-Y.; Kim, S.; Lee, B.; Jeong, G.; Lee, D.H.; Keum, N.; Manson, J.E.; Giovannucci, E.L. Post-diagnosis  <strong>Vitamin D</strong>  supplement use and survival among cancer patients: A meta-analysis. Nutrients 2022,14, 3418. <span>[CrossRef]</span></p>
</li>
<li>
<p>Vaughan-Shaw, P.G.; Buijs, L.F.; Blackmur, J.P.; Theodoratou, E.; Zgaga, L.; Din, F.V.N.; Farrington, S.M.; Dunlop, M.G. The effect of  <strong>Vitamin D</strong>  supplementation on survival in patients with colorectal cancer: Systematic review and meta-analysis of randomised controlled trials. Br. J. Cancer 2020,123,1705-1712. <span>[CrossRef]</span></p>
</li>
<li>
<p>Kuznia, S.; Zhu, A.; Akutsu, T.; Buring, J.E.; Camargo, C.A., Jr.; Cook, N.R.; Chen, L.-J.; Cheng, T.-Y.D.; Hantunen, S.; Lee, I.M. Efficacy of  <strong>Vitamin D</strong> 3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res. Rev. 2023, 87,101923. <span>[CrossRef]</span></p>
</li>
<li>
<p>Wang, L.; Wang, C.; Wang, J.; Huang, X.; Cheng, Y. Longitudinal, observational study on associations between postoperative nutritional  <strong>Vitamin D</strong>  supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci. Rep. 2016, 6, 38962. <span>[CrossRef]</span></p>
</li>
<li>
<p>Madden, J.M.; Murphy, L.; Zgaga, L.; Bennett, K. De novo  <strong>Vitamin D</strong>  supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res. Treat. 2018,172,179-190. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Marshall, D.T.; Savage, S.J.; Garrett-Mayer, E.; Keane, T.E.; Hollis, B.W.; Horst, R.L.; Ambrose, L.H.; Kindy, M.S.; Gattoni-Celli, S.  <strong>Vitamin D</strong> 3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J. Clin. Endocrinol. Metab. 2012, 97, 2315-2324. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Wagner, D.; Trudel, D.; Van der Kwast, T.; Nonn, L.; Giangreco, A.A.; Li, D.; Dias, A.; Cardoza, M.; Laszlo, S.; Hersey, K. Randomized clinical trial of  <strong>Vitamin D</strong> 3 doses on prostatic  <strong>Vitamin D</strong>  metabolite levels and ki67 labeling in prostate cancer patients. J. Clin. Endocrinol. Metab. 2013, 98,1498-1507. <span>[CrossRef]</span> <span>[PubMed]</span></p>
</li>
<li>
<p>Zeichner, S.B.; Koru-Sengul, T.; Shah, N.; Liu, Q.; Markward, N.J.; Montero, A.J.; Glück, S.; Silva, O.; Ahn, E.R. Improved clinical outcomes associated with  <strong>Vitamin D</strong>  supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin. Breast Cancer 2015,15, e1-e11. <span>[CrossRef]</span></p>
</li>
<li>
<p>Amon, U.; Yaguboglu, R.; Ennis, M.; Holick, M.F.; Amon, J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of  <strong>Vitamin D</strong> 3 According to the &ldquo;Coimbra Protocol&rdquo;. Nutrients 2022,14,1575. <span>[CrossRef]</span></p>
</li>
<li>
<p>Finamor, D.C.; Sinigaglia-Coimbra, R.; Neves, L.C.M.; Gutierrez, M.; Silva, J.J.; Torres, L.D.; Surano, F.; Neto, D.J.; Novo, N.F.; Juliano, Y. A pilot study assessing the effect of prolonged administration of high daily doses of  <strong>Vitamin D</strong>  on the clinical course of vitiligo and psoriasis. Derm.-Endocrinol. 2013, 5, 222-234. <span>[CrossRef]</span></p>
</li>
</ul>
<hr>
<h4 id="vitamindwiki--cancercategoriescancer-category-contains">VitaminDWiki – <a href="/categories/cancer">Cancer</a> category contains:</h4>
<hr>
<h4 id="span-stylecolororange87-spanmeta-analyses--in-vitamindwiki-with-cancer-etc-in-the-title"><span style="color:orange;">87 </span>Meta-analyses  in VitaminDWiki with CANCER etc in the title</h4>
<p>This list is automatically updated</p>
<p>{LIST()}</p>
<p>{list max=&ldquo;100&rdquo;}</p>
<!-- {filter categories="82"} -->
<!-- {filter field="title" content="Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma"} -->
<!-- {filter type="wiki page"} -->
<p>{sort mode=&ldquo;modification_date_major_desc&rdquo;}</p>
<p>{OUTPUT(template=&ldquo;table&rdquo;)}</p>
<p>{tableparams allowtableexpansion=&ldquo;n&rdquo; shownbitems=&ldquo;y&rdquo; title=&quot;&quot;}</p>
<pre><code>{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}

{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
</code></pre>
<p>{OUTPUT}</p>
<p>{FORMAT(name=&ldquo;title&rdquo;)}{display name=title format=&ldquo;objectlink&rdquo;}{FORMAT}</p>
<p>{FORMAT(name=&ldquo;modification_date_major&rdquo;)}{display name=modification_date_major format=&ldquo;date&rdquo;}{FORMAT}</p>
<p>{LIST}</p>
<hr>
<h4 id="span-stylecolororange5span--vitamindwiki-loading-dose-pages-with-cancer-etc-in-title"><span style="color:orange;">5+</span>  VitaminDWiki LOADING DOSE pages with CANCER etc in title</h4>
<p>This list is automatically updated</p>
<p>{LIST()}</p>
<p>{list max=&ldquo;50&rdquo;}</p>
<!-- {filter categories="73"} -->
<!-- {filter field="title" content="Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma"} -->
<!-- {filter type="wiki page"} -->
<p>{sort mode=&ldquo;modification_date_major_desc&rdquo;}</p>
<p>{OUTPUT(template=&ldquo;table&rdquo;)}</p>
<p>{tableparams allowtableexpansion=&ldquo;n&rdquo; shownbitems=&ldquo;y&rdquo; title=&quot;&quot;}n</p>
<pre><code>{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}

{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
</code></pre>
<p>{OUTPUT}</p>
<p>{FORMAT(name=&ldquo;title&rdquo;)}{display name=title format=&ldquo;objectlink&rdquo;}{FORMAT}</p>
<p>{FORMAT(name=&ldquo;modification_date_major&rdquo;)}{display name=modification_date_major format=&ldquo;date&rdquo;}{FORMAT}</p>
<p>{LIST}</p>
<hr>
<h4 id="span-stylecolororange726span--vitamindwiki-pages-have-both-cancer--and-vitamin--in-the-title"><span style="color:orange;">726+</span>  VitaminDWiki pages have both CANCER  AND VITAMIN  in the title</h4>
<p>This list is automatically updated</p>
<p><strong>Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.</strong></p>
<p>{LIST()}</p>
<!-- {filter type="wiki page"} -->
<p>{list max=&ldquo;1000&rdquo;}</p>
<!-- {filter field="title" content="cancer AND Vitamin"} -->
<!-- {filter field="title" content="NOT \" K2\""} -->
<p>{sort mode=&ldquo;modification_date_major_desc&rdquo;}</p>
<p>{OUTPUT(template=&ldquo;table&rdquo;)}</p>
<p>{tableparams allowtableexpansion=&ldquo;n&rdquo; shownbitems=&ldquo;y&rdquo; title=&quot;&quot;}</p>
<pre><code>{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}

{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
</code></pre>
<p>{OUTPUT}</p>
<p>{FORMAT(name=&ldquo;title&rdquo;)}{display name=title format=&ldquo;objectlink&rdquo;}{FORMAT}</p>
<p>{FORMAT(name=&ldquo;modification_date_major&rdquo;)}{display name=modification_date_major format=&ldquo;date&rdquo;}{FORMAT}</p>
<p>{LIST}</p>
<hr>
<h4 id="600000-hits-for-cancer-metabolism-vitamin-d-in-google-scholar-oct-2023">600,000 Hits for (cancer metabolism) &ldquo;vitamin d&rdquo; in Google Scholar Oct 2023</h4>
<p><strong><a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C48&amp;q=%28cancer+metabolism%29+%22vitamin+d%22&amp;btnG=">Google Scholar</a></strong></p>
<ul>
<li>
<p>An update on vitamin D signaling and cancer - February 2022 <a href="https://doi.org/10.1016/j.semcancer.2020.05.018">https://doi.org/10.1016/j.semcancer.2020.05.018</a>  FREE PDF</p>
</li>
<li>
<p>Vitamin D and the risk for cancer: A molecular analysis - Feb 2022 <a href="https://doi.org/10.1016/j.bcp.2021.114735">https://doi.org/10.1016/j.bcp.2021.114735</a> FREE PDF</p>
</li>
<li>
<p>New insights into molecules and pathways of cancer metabolism and therapeutic implications - Nov 2020 <a href="https://doi.org/10.1002/cac2.12112">https://doi.org/10.1002/cac2.12112</a> FREE PDF</p>
</li>
</ul>
<p>*Relationship Between Vitamin D Supplementation and Improvement in Body for Carcinogenesis: A Literature Review 2022 - <a href="https://doi.org/10.37275/bsm.v6i2.447">https://doi.org/10.37275/bsm.v6i2.447</a> FREE PDF</p>
<ul>
<li>Metabolism and Colorectal Cancer - Jan 2023 <a href="https://doi.org/10.1146/annurev-pathmechdis-031521-041113">https://doi.org/10.1146/annurev-pathmechdis-031521-041113</a> FREE PDF</li>
</ul>
<pre style="background-color: #e0e0e0;">
<code class="language-text">
Markdown:
--------

&lt;!-- {maketoc Title=&quot;&quot;} --&gt;

---

#### Cancer Metabolism as a Therapeutic Target and Review of Interventions

 Nutrients 2023, 15, 4245. https://doi.org/10.3390/ nu15194245

Matthew T. J. Halma 1,2 , Jack A. Tuszynski3,4,5 and Paul E. Marik ^*

Department of Physics and Astronomy, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands

EbMC Squared CIC, Bath BA2 4BL, UK

Department of Physics, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB T6G 2M9, Canada

Department of Data Science and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland

DIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, I-1029 Turin, Italy

Frontline COVID-19 Critical Care Alliance, Washington, DC 20036, USA * Correspondence: pmarik@flccc.net

&lt;img src=&quot;/attachments/d3.mock.jpg&quot; alt=&quot;image&quot; width=&quot;800&quot;&gt;

Cancer is amenable to low-cost treatments, given that it has a significant metabolic com­ponent, which can be affected through diet and lifestyle change at minimal cost. The Warburg hypothesis states that cancer cells have an altered cell metabolism towards anaerobic glycolysis. Given this metabolic reprogramming in cancer cells, it is possible to target cancers metabolically by depriving them of glucose. In addition to dietary and lifestyle modifications which work on tumors metabolically, there are a panoply of nutritional supplements and repurposed drugs associated with cancer prevention and better treatment outcomes. These interventions and their evidentiary basis are covered in the latter half of this review to guide future cancer treatment.

##### Recommended: Vitamin D (Extracted from PDF)

Vitamin D is synthesized in the human skin through the influence of UV B radiation and is then converted into the active form, 1,25-dihydroxyvitamin D3 (calcitriol), in the kidney &lt;span&gt;[323-325]&lt;/span&gt;. 25-hydroxyvitamin D3 (25(OH)D3) is considered the best indicator of vitamin D status, with a level &gt; 30 ng/mL considered normal, 20-30 ng/mL considered insufficient, and &lt;20 ng/mL considered deficient &lt;span&gt;[324-326]&lt;/span&gt;. Recent data suggest that a level &gt; 50 ng/mL is desirable, and, ideally, targeting a level between 55 and 90 ng/mL is preferable &lt;span&gt;[323,327-329]&lt;/span&gt;. Adequate vitamin D supplementation is important to achieve optimal levels in patients with low vitamin D levels, and using 50,000 IU D3 capsules in divided doses over a few days is recommended &lt;sup&gt;[323,328,329]&lt;/sup&gt; (Supplementary Table S1).

Vitamin D plays a critical role in various physiological pathways, including energy metabolism, immunity, and cellular growth &lt;sup&gt;[330]&lt;/sup&gt;. It has pleiotropic functions and regulates over 1200 genes within the human genome, with a significant role in the modulation of the immune system &lt;sup&gt;[323,331,332]&lt;/sup&gt;. Observational and randomized controlled studies indicate that a low vitamin D status is associated with higher mortality from conditions like cancer and cardiovascular disease &lt;sup&gt;[333,334]&lt;/sup&gt;. Vitamin D deficiency increases the risk of breast, colon, prostate, and other cancers, while supplemental vitamin D intake has an inverse relationship with cancer risk &lt;sup&gt;[324,335]&lt;/sup&gt;. Higher latitudes are associated with increased risk of vitamin D deficiency and various cancers, with vitamin D supplementation likely playing a crucial role in cancer prevention &lt;sup&gt;[324,336]&lt;/sup&gt;. Achieving a vitamin D level of 80 ng/mL may reduce cancer incidence rates by 70% &lt;sup&gt;[337]&lt;/sup&gt;.

 **Mechanism** 

Vitamin D exhibits diverse antineoplastic activity through various pathways. It binds to the vitamin D receptor and induces differentiation and apoptosis; it also inhibits cancer stem cells, proliferation, angiogenesis, and metastatic potential &lt;sup&gt;[338]&lt;/sup&gt;. It promotes apoptosis of cancer cells, inhibits WNT-p catenin signaling, and has anti-inflammatory effects by downregulating nuclear factor-Kp and inhibiting cyclooxygenase expression &lt;span&gt;[339-341]&lt;/span&gt;. Vitamin D also regulates cell cycle, growth factor pathways, and immune responses against tumor cells &lt;sup&gt;[337,342]&lt;/sup&gt;. It triggers autophagic death, promotes cell differentiation, and exhibits anti-angiogenic effects &lt;sup&gt;[337,343,344]&lt;/sup&gt;. These mechanisms collectively contribute to vitamin D&#39;s anticancer effects and may help reduce cancer incidence and mortality &lt;sup&gt;[336]&lt;/sup&gt;.

 **Clinical Evidence** 

Multiple studies indicate that a significant proportion of cancer patients are vitamin D-deficient (level &lt; 20 ng/mL) and that higher plasma 25-hydroxyvitamin D levels are associated with improved survival in colorectal, breast, gastric, and lymphoma cancer patients &lt;span&gt;[334,338,345-351]&lt;/span&gt;. Meta-analyses and clinical trials demonstrate that vitamin D supplementation may reduce cancer mortality and improve survival in cancer patients, especially when used in combination with chemotherapy &lt;span&gt;[352-358]&lt;/span&gt;. SUNSHINE, a clinical trial on metastatic colorectal cancer patients, showed that “high-dose&quot; vitamin D3 (aiming for a level of &gt;50 ng/mL) combined with standard chemotherapy resulted in improved progression-free survival compared to standard-dose vitamin D3 &lt;sup&gt;[338]&lt;/sup&gt;. Adequate vitamin D dosing aiming for a level between 55 and 90 ng/mL may have additional benefits in cancer patients &lt;sup&gt;[338]&lt;/sup&gt;. Vitamin D supplementation is suggested to have additive or synergistic effects when combined with conventional chemotherapy &lt;sup&gt;[359,360]&lt;/sup&gt;.

 **Dosing Recommendation** 

Vitamin D supplementation is likely beneficial for most types of cancers, especially breast, colorectal, gastric, esophageal, lung, and prostate cancer, lymphomas, and melanoma. Due to the severe vitamin D deficiency observed in most cancer patients, a high loading dose of vitamin D is recommended, followed by dose titration aiming for a level of &gt;50 ng/mL (target 55-90 ng/mL). Some types of cancer may require higher levels, up to 150 ng/mL, to halt growth and metastasis. Daily doses of 20,000 to 50,000 IU/day are suggested until the desired vitamin D level is reached. It is important to monitor vitamin D levels to ensure appropriate maintenance dosing, and daily dosing of vitamin D3 is preferred over large intermittent bolus dosing. Vitamin K2 (menaquinone (MK4/MK7)) and magnesium are recommended in conjunction with high vitamin D doses (&gt;8000 IU/day). Measuring parathyroid levels and calcium levels can help titrate the vitamin D dose according to the Coimbra Protocol &lt;sup&gt;[65,66]&lt;/sup&gt;.

 **[&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;Download the PDF from VitaminDWiki ](/attachments/d3.mock.pdf)** 

##### 39 Vitamin D references (of 520 references)

* Wimalawansa, S.J. Physiological Basis for Using  **Vitamin D**  to Improve Health. Biomedicines 2023,11,1542. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Holick, M.F.  **Vitamin D**  Deficiency. N. Engl. J. Med. 2002, 357, 266-281. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Brandi, M.L. Indications on the use of  **Vitamin D**  and  **Vitamin D**  metabolites in clinical phenotypes. Clin. Cases Miner. Bone Metab. 2010, 7, 243-250.

* Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, PJ. Prevalence of  **Vitamin D**  Insufficiency in an Adult Normal Population. Osteoporos. lnt. 1997, 7, 439-443. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Vieth, R. Why the optimal requirement for  **Vitamin D** 3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients 2022,14, 2997. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Wimalawansa, S.J. Effective and practical ways to overcome  **Vitamin D**  deficiency. J. Fam. Med. Community Health 2021, 8,1185.

* Carlberg, C.; Velleuer, E.  **Vitamin D**  and the risk for cancer: A molecular analysis. Biochem. Pharmacol. 2022,196,114735. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C.  **Vitamin D** : Modulator of the immune system. Curr. Opin. Pharmacol. 2010,10, 482-496. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Bartley, J.  **Vitamin D** : Emerging roles in infection and immunity. Expert Rev. Anti-lnfect. Ther. 2010, 8,1359-1369. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B.  **Vitamin D**  and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F.  **Vitamin D**  status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol. 2015, 33, 3503. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J.  **Vitamin D**  and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN 2019, 30,170-184. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Zhang, Y.; Fang, F.; Tang, J.; Jia, L.; Feng, Y.; Xu, P.; Faramand, A. Association between  **Vitamin D**  supplementation and mortality: Systematic review and meta-analysis. BMJ 2019, 366, l4673. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Muñoz, A.; Grant, W.B.  **Vitamin D**  and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022, 14,1448. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Ng, K.; Nimeiri, H.S.; McCleary, N.J.; Abrams, T.A.; Yurgelun, M.B.; Cleary, J.M.; Rubinson, D.A.; Schrag, D.; Miksad, R.; Bullock, A.J. Effect of high-dose vs standard-dose  **Vitamin D** 3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA 2019, 321,1370-1379. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Díaz, G.D.; Paraskeva, C.; Thomas, M.G.; Binderup, L.; Hague, A. Apoptosis is induced by the active metabolite of  **Vitamin D** 3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res. 2000, 60, 2304-2312. &lt;span&gt;[PubMed]&lt;/span&gt;

* Feldman, D.; Krishnan, A.V.; Swami, S.; Giovannucci, E.; Feldman, B.J. The role of  **Vitamin D**  in reducing cancer risk and progression. Nat. Rev. Cancer 2014,14, 342-357. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Mathieu, C.; Adorini, L. The coming of age of 1, 25-dihydroxy **Vitamin D** 3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8,174-179. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Yang, E.S.; Burnstein, K.L.  **Vitamin D**  inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278, 46862-46868. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Larriba, M.J.; García de Herreros, A.; Muñoz, A.  **Vitamin D**  and the epithelial to mesenchymal transition. Stem Cells lnt. 2016, 2016, 6213872. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Bernardi, R.J.; Johnson, C.S.; Modzelewski, R.A.; Trump, D.L. Antiproliferative effects of 1a, 25-dihydroxy **Vitamin D** 3 and  **Vitamin D**  analogs on tumor-derived endothelial cells. Endocrinology 2002,143, 2508-2514. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Ng, K.; Meyerhardt, J.A.; Wu, K.; Feskanich, D.; Hollis, B.W.; Giovannucci, E.L.; Fuchs, C.S. Circulating 25-hydroxy **Vitamin D**  levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 2984-2991. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Johansson, H.; Spadola, G.; Tosti, G.; Mandalà, M.; Minisini, A.M.; Queirolo, P.; Aristarco, V.; Baldini, F.; Cocorocchio, E.; Albertazzi, E.  **Vitamin D**  supplementation and disease-free survival in stage II melanoma: A randomized placebo controlled trial. Nutrients 2021,13,1931. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Yuan, C.; Sato, K.; Hollis, B.W.; Zhang, S.; Niedzwiecki, D.; Ou, F.-S.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F.; Lenz, H.-J. Plasma 25-hydroxy **Vitamin D**  levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin. Cancer Res. 2019, 25,7497-7505. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Mezawa, H.; Sugiura, T.; Watanabe, M.; Norizoe, C.; Takahashi, D.; Shimojima, A.; Tamez, S.; Tsutsumi, Y.; Yanaga, K.; Urashima, M. Serum  **Vitamin D**  levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer 2010,10, 347. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma  **Vitamin D**  concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol. 2014, 32, 2430-2439. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Toriola, A.T.; Nguyen, N.; Scheitler-Ring, K.; Colditz, G.A. Circulating 25-hydroxy **Vitamin D**  levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol. Biomark. Prev. 2014, 23, 917-933. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxy **Vitamin D**  and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012, 23, 363-370. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Chen, Q.-Y.; Kim, S.; Lee, B.; Jeong, G.; Lee, D.H.; Keum, N.; Manson, J.E.; Giovannucci, E.L. Post-diagnosis  **Vitamin D**  supplement use and survival among cancer patients: A meta-analysis. Nutrients 2022,14, 3418. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Vaughan-Shaw, P.G.; Buijs, L.F.; Blackmur, J.P.; Theodoratou, E.; Zgaga, L.; Din, F.V.N.; Farrington, S.M.; Dunlop, M.G. The effect of  **Vitamin D**  supplementation on survival in patients with colorectal cancer: Systematic review and meta-analysis of randomised controlled trials. Br. J. Cancer 2020,123,1705-1712. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Kuznia, S.; Zhu, A.; Akutsu, T.; Buring, J.E.; Camargo, C.A., Jr.; Cook, N.R.; Chen, L.-J.; Cheng, T.-Y.D.; Hantunen, S.; Lee, I.M. Efficacy of  **Vitamin D** 3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res. Rev. 2023, 87,101923. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Wang, L.; Wang, C.; Wang, J.; Huang, X.; Cheng, Y. Longitudinal, observational study on associations between postoperative nutritional  **Vitamin D**  supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci. Rep. 2016, 6, 38962. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Madden, J.M.; Murphy, L.; Zgaga, L.; Bennett, K. De novo  **Vitamin D**  supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res. Treat. 2018,172,179-190. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Marshall, D.T.; Savage, S.J.; Garrett-Mayer, E.; Keane, T.E.; Hollis, B.W.; Horst, R.L.; Ambrose, L.H.; Kindy, M.S.; Gattoni-Celli, S.  **Vitamin D** 3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J. Clin. Endocrinol. Metab. 2012, 97, 2315-2324. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Wagner, D.; Trudel, D.; Van der Kwast, T.; Nonn, L.; Giangreco, A.A.; Li, D.; Dias, A.; Cardoza, M.; Laszlo, S.; Hersey, K. Randomized clinical trial of  **Vitamin D** 3 doses on prostatic  **Vitamin D**  metabolite levels and ki67 labeling in prostate cancer patients. J. Clin. Endocrinol. Metab. 2013, 98,1498-1507. &lt;span&gt;[CrossRef]&lt;/span&gt; &lt;span&gt;[PubMed]&lt;/span&gt;

* Zeichner, S.B.; Koru-Sengul, T.; Shah, N.; Liu, Q.; Markward, N.J.; Montero, A.J.; Glück, S.; Silva, O.; Ahn, E.R. Improved clinical outcomes associated with  **Vitamin D**  supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin. Breast Cancer 2015,15, e1-e11. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Amon, U.; Yaguboglu, R.; Ennis, M.; Holick, M.F.; Amon, J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of  **Vitamin D** 3 According to the &quot;Coimbra Protocol&quot;. Nutrients 2022,14,1575. &lt;span&gt;[CrossRef]&lt;/span&gt;

* Finamor, D.C.; Sinigaglia-Coimbra, R.; Neves, L.C.M.; Gutierrez, M.; Silva, J.J.; Torres, L.D.; Surano, F.; Neto, D.J.; Novo, N.F.; Juliano, Y. A pilot study assessing the effect of prolonged administration of high daily doses of  **Vitamin D**  on the clinical course of vitiligo and psoriasis. Derm.-Endocrinol. 2013, 5, 222-234. &lt;span&gt;[CrossRef]&lt;/span&gt;

---

#### VitaminDWiki – [Cancer](/categories/cancer) category contains:

---

####  &lt;span style=&quot;color:orange;&quot;&gt;87 &lt;/span&gt;Meta-analyses  in VitaminDWiki with CANCER etc in the title

This list is automatically updated

{LIST()}

{list max=&quot;100&quot;}

&lt;!-- {filter categories=&quot;82&quot;} --&gt;

&lt;!-- {filter field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;} --&gt;

&lt;!-- {filter type=&quot;wiki page&quot;} --&gt;

{sort mode=&quot;modification_date_major_desc&quot;}

{OUTPUT(template=&quot;table&quot;)}

   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}

    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}

    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}

{OUTPUT}

{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}

{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}

{LIST}

---

####  &lt;span style=&quot;color:orange;&quot;&gt;5+&lt;/span&gt;  VitaminDWiki LOADING DOSE pages with CANCER etc in title

This list is automatically updated

{LIST()}

{list max=&quot;50&quot;}

&lt;!-- {filter categories=&quot;73&quot;} --&gt;

&lt;!-- {filter field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;} --&gt;

&lt;!-- {filter type=&quot;wiki page&quot;} --&gt;

{sort mode=&quot;modification_date_major_desc&quot;}

{OUTPUT(template=&quot;table&quot;)}

   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n

    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}

    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}

{OUTPUT}

{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}

{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}

{LIST}

---

####  &lt;span style=&quot;color:orange;&quot;&gt;726+&lt;/span&gt;  VitaminDWiki pages have both CANCER  AND VITAMIN  in the title

This list is automatically updated

 **Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.** 

{LIST()}

  
&lt;!-- {filter type=&quot;wiki page&quot;} --&gt;

  {list max=&quot;1000&quot;}

  
&lt;!-- {filter field=&quot;title&quot; content=&quot;cancer AND Vitamin&quot;} --&gt;

  
&lt;!-- {filter field=&quot;title&quot; content=&quot;NOT \&quot; K2\&quot;&quot;} --&gt;

  {sort mode=&quot;modification_date_major_desc&quot;}

{OUTPUT(template=&quot;table&quot;)}

   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}

    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}

    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}

{OUTPUT}

{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}

{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}

{LIST}

---

#### 600,000 Hits for (cancer metabolism) &quot;vitamin d&quot; in Google Scholar Oct 2023

 **[Google Scholar](https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C48&amp;q=%28cancer+metabolism%29+%22vitamin+d%22&amp;btnG=)** 

*  An update on vitamin D signaling and cancer - February 2022 https://doi.org/10.1016/j.semcancer.2020.05.018  FREE PDF

 * Vitamin D and the risk for cancer: A molecular analysis - Feb 2022 https://doi.org/10.1016/j.bcp.2021.114735 FREE PDF

 * New insights into molecules and pathways of cancer metabolism and therapeutic implications - Nov 2020 https://doi.org/10.1002/cac2.12112 FREE PDF

 *Relationship Between Vitamin D Supplementation and Improvement in Body for Carcinogenesis: A Literature Review 2022 - https://doi.org/10.37275/bsm.v6i2.447 FREE PDF

*  Metabolism and Colorectal Cancer - Jan 2023 https://doi.org/10.1146/annurev-pathmechdis-031521-041113 FREE PDF

AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Cancer Metabolism as a Therapeutic Target and Review of Interventions`
│   inner_content: `Cancer Metabolism as a Therapeutic Target and Review of Interventions`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Cancer Metabolism as a Therapeutic Target and Review of Interventions`
│   │   inner_content: `Cancer Metabolism as a Therapeutic Target and Review of Interventions`├── TextNode
│   full_match: `\n Nutrients 2023, 15, 4245. https://doi.org/10.3390/ nu15194245\nMatthew T. J. Halma 1,2 , Jack A. Tuszynski3,4,5 and Paul E. Marik ^*\nDepartment of Physics and Astronomy, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands\nEbMC Squared CIC, Bath BA2 4BL, UK\nDepartment of Physics, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB T6G 2M9, Canada\nDepartment of Data Science and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland\nDIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, I-1029 Turin, Italy\nFrontline COVID-19 Critical Care Alliance, Washington, DC 20036, USA * Correspondence: pmarik@flccc.net\n\n`
│   inner_content: `\n Nutrients 2023, 15, 4245. https://doi.org/10.3390/ nu15194245\nMatthew T. J. Halma 1,2 , Jack A. Tuszynski3,4,5 and Paul E. Marik ^*\nDepartment of Physics and Astronomy, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands\nEbMC Squared CIC, Bath BA2 4BL, UK\nDepartment of Physics, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB T6G 2M9, Canada\nDepartment of Data Science and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland\nDIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, I-1029 Turin, Italy\nFrontline COVID-19 Critical Care Alliance, Washington, DC 20036, USA * Correspondence: pmarik@flccc.net\n\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;20157&quot; width=&quot;800&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;20157&quot; width=&quot;800&quot;
│   │   type: attId
│   │   attId: 20157
│   │   width: 800├── TextNode
│   full_match: `\nCancer is amenable to low-cost treatments, given that it has a significant metabolic com­ponent, which can be affected through diet and lifestyle change at minimal cost. The Warburg hypothesis states that cancer cells have an altered cell metabolism towards anaerobic glycolysis. Given this metabolic reprogramming in cancer cells, it is possible to target cancers metabolically by depriving them of glucose. In addition to dietary and lifestyle modifications which work on tumors metabolically, there are a panoply of nutritional supplements and repurposed drugs associated with cancer prevention and better treatment outcomes. These interventions and their evidentiary basis are covered in the latter half of this review to guide future cancer treatment.\n`
│   inner_content: `\nCancer is amenable to low-cost treatments, given that it has a significant metabolic com­ponent, which can be affected through diet and lifestyle change at minimal cost. The Warburg hypothesis states that cancer cells have an altered cell metabolism towards anaerobic glycolysis. Given this metabolic reprogramming in cancer cells, it is possible to target cancers metabolically by depriving them of glucose. In addition to dietary and lifestyle modifications which work on tumors metabolically, there are a panoply of nutritional supplements and repurposed drugs associated with cancer prevention and better treatment outcomes. These interventions and their evidentiary basis are covered in the latter half of this review to guide future cancer treatment.\n`├── HeadingNode
│   full_match: `\n!!!!!Recommended: Vitamin D (Extracted from PDF)`
│   inner_content: `Recommended: Vitamin D (Extracted from PDF)`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Recommended: Vitamin D (Extracted from PDF)`
│   │   inner_content: `Recommended: Vitamin D (Extracted from PDF)`├── TextNode
│   full_match: `\nVitamin D is synthesized in the human skin through the influence of UV B radiation and is then converted into the active form, 1,25-dihydroxyvitamin D3 (calcitriol), in the kidney `
│   inner_content: `\nVitamin D is synthesized in the human skin through the influence of UV B radiation and is then converted into the active form, 1,25-dihydroxyvitamin D3 (calcitriol), in the kidney `├── LinkNode
│   full_match: `[323-325]`
│   inner_content: `323-325`
│   url: `323-325`
│   children:
│   ├── TextNode
│   │   full_match: `323-325`
│   │   inner_content: `323-325`├── TextNode
│   full_match: `. 25-hydroxyvitamin D3 (25(OH)D3) is considered the best indicator of vitamin D status, with a level &gt; 30 ng/mL considered normal, 20-30 ng/mL considered insufficient, and &lt;20 ng/mL considered deficient `
│   inner_content: `. 25-hydroxyvitamin D3 (25(OH)D3) is considered the best indicator of vitamin D status, with a level &gt; 30 ng/mL considered normal, 20-30 ng/mL considered insufficient, and &lt;20 ng/mL considered deficient `├── LinkNode
│   full_match: `[324-326]`
│   inner_content: `324-326`
│   url: `324-326`
│   children:
│   ├── TextNode
│   │   full_match: `324-326`
│   │   inner_content: `324-326`├── TextNode
│   full_match: `. Recent data suggest that a level &gt; 50 ng/mL is desirable, and, ideally, targeting a level between 55 and 90 ng/mL is preferable `
│   inner_content: `. Recent data suggest that a level &gt; 50 ng/mL is desirable, and, ideally, targeting a level between 55 and 90 ng/mL is preferable `├── LinkNode
│   full_match: `[323,327-329]`
│   inner_content: `323,327-329`
│   url: `323,327-329`
│   children:
│   ├── TextNode
│   │   full_match: `323,327-329`
│   │   inner_content: `323,327-329`├── TextNode
│   full_match: `. Adequate vitamin D supplementation is important to achieve optimal levels in patients with low vitamin D levels, and using 50,000 IU D3 capsules in divided doses over a few days is recommended `
│   inner_content: `. Adequate vitamin D supplementation is important to achieve optimal levels in patients with low vitamin D levels, and using 50,000 IU D3 capsules in divided doses over a few days is recommended `├── LinkNode
│   full_match: `[323,328,329]`
│   inner_content: `323,328,329`
│   url: `323,328,329`
│   children:
│   ├── TextNode
│   │   full_match: `323,328,329`
│   │   inner_content: `323,328,329`├── TextNode
│   full_match: ` (Supplementary Table S1).\nVitamin D plays a critical role in various physiological pathways, including energy metabolism, immunity, and cellular growth `
│   inner_content: ` (Supplementary Table S1).\nVitamin D plays a critical role in various physiological pathways, including energy metabolism, immunity, and cellular growth `├── LinkNode
│   full_match: `[330]`
│   inner_content: `330`
│   url: `330`
│   children:
│   ├── TextNode
│   │   full_match: `330`
│   │   inner_content: `330`├── TextNode
│   full_match: `. It has pleiotropic functions and regulates over 1200 genes within the human genome, with a significant role in the modulation of the immune system `
│   inner_content: `. It has pleiotropic functions and regulates over 1200 genes within the human genome, with a significant role in the modulation of the immune system `├── LinkNode
│   full_match: `[323,331,332]`
│   inner_content: `323,331,332`
│   url: `323,331,332`
│   children:
│   ├── TextNode
│   │   full_match: `323,331,332`
│   │   inner_content: `323,331,332`├── TextNode
│   full_match: `. Observational and randomized controlled studies indicate that a low vitamin D status is associated with higher mortality from conditions like cancer and cardiovascular disease `
│   inner_content: `. Observational and randomized controlled studies indicate that a low vitamin D status is associated with higher mortality from conditions like cancer and cardiovascular disease `├── LinkNode
│   full_match: `[333,334]`
│   inner_content: `333,334`
│   url: `333,334`
│   children:
│   ├── TextNode
│   │   full_match: `333,334`
│   │   inner_content: `333,334`├── TextNode
│   full_match: `. Vitamin D deficiency increases the risk of breast, colon, prostate, and other cancers, while supplemental vitamin D intake has an inverse relationship with cancer risk `
│   inner_content: `. Vitamin D deficiency increases the risk of breast, colon, prostate, and other cancers, while supplemental vitamin D intake has an inverse relationship with cancer risk `├── LinkNode
│   full_match: `[324,335]`
│   inner_content: `324,335`
│   url: `324,335`
│   children:
│   ├── TextNode
│   │   full_match: `324,335`
│   │   inner_content: `324,335`├── TextNode
│   full_match: `. Higher latitudes are associated with increased risk of vitamin D deficiency and various cancers, with vitamin D supplementation likely playing a crucial role in cancer prevention `
│   inner_content: `. Higher latitudes are associated with increased risk of vitamin D deficiency and various cancers, with vitamin D supplementation likely playing a crucial role in cancer prevention `├── LinkNode
│   full_match: `[324,336]`
│   inner_content: `324,336`
│   url: `324,336`
│   children:
│   ├── TextNode
│   │   full_match: `324,336`
│   │   inner_content: `324,336`├── TextNode
│   full_match: `. Achieving a vitamin D level of 80 ng/mL may reduce cancer incidence rates by 70% `
│   inner_content: `. Achieving a vitamin D level of 80 ng/mL may reduce cancer incidence rates by 70% `├── LinkNode
│   full_match: `[337]`
│   inner_content: `337`
│   url: `337`
│   children:
│   ├── TextNode
│   │   full_match: `337`
│   │   inner_content: `337`├── TextNode
│   full_match: `.\n`
│   inner_content: `.\n`├── BoldNode
│   full_match: `__Mechanism__`
│   inner_content: `Mechanism`
│   children:
│   ├── TextNode
│   │   full_match: `Mechanism`
│   │   inner_content: `Mechanism`├── TextNode
│   full_match: `\nVitamin D exhibits diverse antineoplastic activity through various pathways. It binds to the vitamin D receptor and induces differentiation and apoptosis; it also inhibits cancer stem cells, proliferation, angiogenesis, and metastatic potential `
│   inner_content: `\nVitamin D exhibits diverse antineoplastic activity through various pathways. It binds to the vitamin D receptor and induces differentiation and apoptosis; it also inhibits cancer stem cells, proliferation, angiogenesis, and metastatic potential `├── LinkNode
│   full_match: `[338]`
│   inner_content: `338`
│   url: `338`
│   children:
│   ├── TextNode
│   │   full_match: `338`
│   │   inner_content: `338`├── TextNode
│   full_match: `. It promotes apoptosis of cancer cells, inhibits WNT-p catenin signaling, and has anti-inflammatory effects by downregulating nuclear factor-Kp and inhibiting cyclooxygenase expression `
│   inner_content: `. It promotes apoptosis of cancer cells, inhibits WNT-p catenin signaling, and has anti-inflammatory effects by downregulating nuclear factor-Kp and inhibiting cyclooxygenase expression `├── LinkNode
│   full_match: `[339-341]`
│   inner_content: `339-341`
│   url: `339-341`
│   children:
│   ├── TextNode
│   │   full_match: `339-341`
│   │   inner_content: `339-341`├── TextNode
│   full_match: `. Vitamin D also regulates cell cycle, growth factor pathways, and immune responses against tumor cells `
│   inner_content: `. Vitamin D also regulates cell cycle, growth factor pathways, and immune responses against tumor cells `├── LinkNode
│   full_match: `[337,342]`
│   inner_content: `337,342`
│   url: `337,342`
│   children:
│   ├── TextNode
│   │   full_match: `337,342`
│   │   inner_content: `337,342`├── TextNode
│   full_match: `. It triggers autophagic death, promotes cell differentiation, and exhibits anti-angiogenic effects `
│   inner_content: `. It triggers autophagic death, promotes cell differentiation, and exhibits anti-angiogenic effects `├── LinkNode
│   full_match: `[337,343,344]`
│   inner_content: `337,343,344`
│   url: `337,343,344`
│   children:
│   ├── TextNode
│   │   full_match: `337,343,344`
│   │   inner_content: `337,343,344`├── TextNode
│   full_match: `. These mechanisms collectively contribute to vitamin D&#39;s anticancer effects and may help reduce cancer incidence and mortality `
│   inner_content: `. These mechanisms collectively contribute to vitamin D&#39;s anticancer effects and may help reduce cancer incidence and mortality `├── LinkNode
│   full_match: `[336]`
│   inner_content: `336`
│   url: `336`
│   children:
│   ├── TextNode
│   │   full_match: `336`
│   │   inner_content: `336`├── TextNode
│   full_match: `.\n`
│   inner_content: `.\n`├── BoldNode
│   full_match: `__Clinical Evidence__`
│   inner_content: `Clinical Evidence`
│   children:
│   ├── TextNode
│   │   full_match: `Clinical Evidence`
│   │   inner_content: `Clinical Evidence`├── TextNode
│   full_match: `\nMultiple studies indicate that a significant proportion of cancer patients are vitamin D-deficient (level &lt; 20 ng/mL) and that higher plasma 25-hydroxyvitamin D levels are associated with improved survival in colorectal, breast, gastric, and lymphoma cancer patients `
│   inner_content: `\nMultiple studies indicate that a significant proportion of cancer patients are vitamin D-deficient (level &lt; 20 ng/mL) and that higher plasma 25-hydroxyvitamin D levels are associated with improved survival in colorectal, breast, gastric, and lymphoma cancer patients `├── LinkNode
│   full_match: `[334,338,345-351]`
│   inner_content: `334,338,345-351`
│   url: `334,338,345-351`
│   children:
│   ├── TextNode
│   │   full_match: `334,338,345-351`
│   │   inner_content: `334,338,345-351`├── TextNode
│   full_match: `. Meta-analyses and clinical trials demonstrate that vitamin D supplementation may reduce cancer mortality and improve survival in cancer patients, especially when used in combination with chemotherapy `
│   inner_content: `. Meta-analyses and clinical trials demonstrate that vitamin D supplementation may reduce cancer mortality and improve survival in cancer patients, especially when used in combination with chemotherapy `├── LinkNode
│   full_match: `[352-358]`
│   inner_content: `352-358`
│   url: `352-358`
│   children:
│   ├── TextNode
│   │   full_match: `352-358`
│   │   inner_content: `352-358`├── TextNode
│   full_match: `. SUNSHINE, a clinical trial on metastatic colorectal cancer patients, showed that “high-dose&quot; vitamin D3 (aiming for a level of &gt;50 ng/mL) combined with standard chemotherapy resulted in improved progression-free survival compared to standard-dose vitamin D3 `
│   inner_content: `. SUNSHINE, a clinical trial on metastatic colorectal cancer patients, showed that “high-dose&quot; vitamin D3 (aiming for a level of &gt;50 ng/mL) combined with standard chemotherapy resulted in improved progression-free survival compared to standard-dose vitamin D3 `├── LinkNode
│   full_match: `[338]`
│   inner_content: `338`
│   url: `338`
│   children:
│   ├── TextNode
│   │   full_match: `338`
│   │   inner_content: `338`├── TextNode
│   full_match: `. Adequate vitamin D dosing aiming for a level between 55 and 90 ng/mL may have additional benefits in cancer patients `
│   inner_content: `. Adequate vitamin D dosing aiming for a level between 55 and 90 ng/mL may have additional benefits in cancer patients `├── LinkNode
│   full_match: `[338]`
│   inner_content: `338`
│   url: `338`
│   children:
│   ├── TextNode
│   │   full_match: `338`
│   │   inner_content: `338`├── TextNode
│   full_match: `. Vitamin D supplementation is suggested to have additive or synergistic effects when combined with conventional chemotherapy `
│   inner_content: `. Vitamin D supplementation is suggested to have additive or synergistic effects when combined with conventional chemotherapy `├── LinkNode
│   full_match: `[359,360]`
│   inner_content: `359,360`
│   url: `359,360`
│   children:
│   ├── TextNode
│   │   full_match: `359,360`
│   │   inner_content: `359,360`├── TextNode
│   full_match: `.\n`
│   inner_content: `.\n`├── BoldNode
│   full_match: `__Dosing Recommendation__`
│   inner_content: `Dosing Recommendation`
│   children:
│   ├── TextNode
│   │   full_match: `Dosing Recommendation`
│   │   inner_content: `Dosing Recommendation`├── TextNode
│   full_match: `\nVitamin D supplementation is likely beneficial for most types of cancers, especially breast, colorectal, gastric, esophageal, lung, and prostate cancer, lymphomas, and melanoma. Due to the severe vitamin D deficiency observed in most cancer patients, a high loading dose of vitamin D is recommended, followed by dose titration aiming for a level of &gt;50 ng/mL (target 55-90 ng/mL). Some types of cancer may require higher levels, up to 150 ng/mL, to halt growth and metastasis. Daily doses of 20,000 to 50,000 IU/day are suggested until the desired vitamin D level is reached. It is important to monitor vitamin D levels to ensure appropriate maintenance dosing, and daily dosing of vitamin D3 is preferred over large intermittent bolus dosing. Vitamin K2 (menaquinone (MK4/MK7)) and magnesium are recommended in conjunction with high vitamin D doses (&gt;8000 IU/day). Measuring parathyroid levels and calcium levels can help titrate the vitamin D dose according to the Coimbra Protocol `
│   inner_content: `\nVitamin D supplementation is likely beneficial for most types of cancers, especially breast, colorectal, gastric, esophageal, lung, and prostate cancer, lymphomas, and melanoma. Due to the severe vitamin D deficiency observed in most cancer patients, a high loading dose of vitamin D is recommended, followed by dose titration aiming for a level of &gt;50 ng/mL (target 55-90 ng/mL). Some types of cancer may require higher levels, up to 150 ng/mL, to halt growth and metastasis. Daily doses of 20,000 to 50,000 IU/day are suggested until the desired vitamin D level is reached. It is important to monitor vitamin D levels to ensure appropriate maintenance dosing, and daily dosing of vitamin D3 is preferred over large intermittent bolus dosing. Vitamin K2 (menaquinone (MK4/MK7)) and magnesium are recommended in conjunction with high vitamin D doses (&gt;8000 IU/day). Measuring parathyroid levels and calcium levels can help titrate the vitamin D dose according to the Coimbra Protocol `├── LinkNode
│   full_match: `[65,66]`
│   inner_content: `65,66`
│   url: `65,66`
│   children:
│   ├── TextNode
│   │   full_match: `65,66`
│   │   inner_content: `65,66`├── TextNode
│   full_match: `.\n`
│   inner_content: `.\n`├── FontNode
│   full_match: `{FONT(size=&quot;22&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;20201&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;20201&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;22&quot;
│   │   size: 22
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;20201&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;20201&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;20201&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;20201&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 20201
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── HeadingNode
│   full_match: `!!!!!39 Vitamin D references (of 520 references)`
│   inner_content: `39 Vitamin D references (of 520 references)`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `39 Vitamin D references (of 520 references)`
│   │   inner_content: `39 Vitamin D references (of 520 references)`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Wimalawansa, S.J. Physiological Basis for Using __Vitamin D__ to Improve Health. Biomedicines 2023,11,1542. [CrossRef]`
│   inner_content: `Wimalawansa, S.J. Physiological Basis for Using __Vitamin D__ to Improve Health. Biomedicines 2023,11,1542. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wimalawansa, S.J. Physiological Basis for Using `
│   │   inner_content: `Wimalawansa, S.J. Physiological Basis for Using `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` to Improve Health. Biomedicines 2023,11,1542. `
│   │   inner_content: ` to Improve Health. Biomedicines 2023,11,1542. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Holick, M.F. __Vitamin D__ Deficiency. N. Engl. J. Med. 2002, 357, 266-281. [CrossRef]`
│   inner_content: `Holick, M.F. __Vitamin D__ Deficiency. N. Engl. J. Med. 2002, 357, 266-281. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Holick, M.F. `
│   │   inner_content: `Holick, M.F. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` Deficiency. N. Engl. J. Med. 2002, 357, 266-281. `
│   │   inner_content: ` Deficiency. N. Engl. J. Med. 2002, 357, 266-281. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Brandi, M.L. Indications on the use of __Vitamin D__ and __Vitamin D__ metabolites in clinical phenotypes. Clin. Cases Miner. Bone Metab. 2010, 7, 243-250.`
│   inner_content: `Brandi, M.L. Indications on the use of __Vitamin D__ and __Vitamin D__ metabolites in clinical phenotypes. Clin. Cases Miner. Bone Metab. 2010, 7, 243-250.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Brandi, M.L. Indications on the use of `
│   │   inner_content: `Brandi, M.L. Indications on the use of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` and `
│   │   inner_content: ` and `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` metabolites in clinical phenotypes. Clin. Cases Miner. Bone Metab. 2010, 7, 243-250.`
│   │   inner_content: ` metabolites in clinical phenotypes. Clin. Cases Miner. Bone Metab. 2010, 7, 243-250.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, PJ. Prevalence of __Vitamin D__ Insufficiency in an Adult Normal Population. Osteoporos. lnt. 1997, 7, 439-443. [CrossRef]`
│   inner_content: `Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, PJ. Prevalence of __Vitamin D__ Insufficiency in an Adult Normal Population. Osteoporos. lnt. 1997, 7, 439-443. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, PJ. Prevalence of `
│   │   inner_content: `Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, PJ. Prevalence of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` Insufficiency in an Adult Normal Population. Osteoporos. lnt. 1997, 7, 439-443. `
│   │   inner_content: ` Insufficiency in an Adult Normal Population. Osteoporos. lnt. 1997, 7, 439-443. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vieth, R. Why the optimal requirement for __Vitamin D__3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579. [CrossRef]`
│   inner_content: `Vieth, R. Why the optimal requirement for __Vitamin D__3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vieth, R. Why the optimal requirement for `
│   │   inner_content: `Vieth, R. Why the optimal requirement for `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579. `
│   │   inner_content: `3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients 2022,14, 2997. [CrossRef]`
│   inner_content: `Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients 2022,14, 2997. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients 2022,14, 2997. `
│   │   inner_content: `Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients 2022,14, 2997. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Wimalawansa, S.J. Effective and practical ways to overcome __Vitamin D__ deficiency. J. Fam. Med. Community Health 2021, 8,1185.`
│   inner_content: `Wimalawansa, S.J. Effective and practical ways to overcome __Vitamin D__ deficiency. J. Fam. Med. Community Health 2021, 8,1185.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wimalawansa, S.J. Effective and practical ways to overcome `
│   │   inner_content: `Wimalawansa, S.J. Effective and practical ways to overcome `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` deficiency. J. Fam. Med. Community Health 2021, 8,1185.`
│   │   inner_content: ` deficiency. J. Fam. Med. Community Health 2021, 8,1185.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Carlberg, C.; Velleuer, E. __Vitamin D__ and the risk for cancer: A molecular analysis. Biochem. Pharmacol. 2022,196,114735. [CrossRef]`
│   inner_content: `Carlberg, C.; Velleuer, E. __Vitamin D__ and the risk for cancer: A molecular analysis. Biochem. Pharmacol. 2022,196,114735. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Carlberg, C.; Velleuer, E. `
│   │   inner_content: `Carlberg, C.; Velleuer, E. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` and the risk for cancer: A molecular analysis. Biochem. Pharmacol. 2022,196,114735. `
│   │   inner_content: ` and the risk for cancer: A molecular analysis. Biochem. Pharmacol. 2022,196,114735. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. __Vitamin D__: Modulator of the immune system. Curr. Opin. Pharmacol. 2010,10, 482-496. [CrossRef]`
│   inner_content: `Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. __Vitamin D__: Modulator of the immune system. Curr. Opin. Pharmacol. 2010,10, 482-496. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. `
│   │   inner_content: `Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `: Modulator of the immune system. Curr. Opin. Pharmacol. 2010,10, 482-496. `
│   │   inner_content: `: Modulator of the immune system. Curr. Opin. Pharmacol. 2010,10, 482-496. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Bartley, J. __Vitamin D__: Emerging roles in infection and immunity. Expert Rev. Anti-lnfect. Ther. 2010, 8,1359-1369. [CrossRef] [PubMed]`
│   inner_content: `Bartley, J. __Vitamin D__: Emerging roles in infection and immunity. Expert Rev. Anti-lnfect. Ther. 2010, 8,1359-1369. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bartley, J. `
│   │   inner_content: `Bartley, J. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `: Emerging roles in infection and immunity. Expert Rev. Anti-lnfect. Ther. 2010, 8,1359-1369. `
│   │   inner_content: `: Emerging roles in infection and immunity. Expert Rev. Anti-lnfect. Ther. 2010, 8,1359-1369. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B. __Vitamin D__ and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. [CrossRef] [PubMed]`
│   inner_content: `Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B. __Vitamin D__ and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B. `
│   │   inner_content: `Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. `
│   │   inner_content: ` and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F. __Vitamin D__ status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol. 2015, 33, 3503. [CrossRef]`
│   inner_content: `Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F. __Vitamin D__ status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol. 2015, 33, 3503. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F. `
│   │   inner_content: `Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol. 2015, 33, 3503. `
│   │   inner_content: ` status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol. 2015, 33, 3503. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J. __Vitamin D__ and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN 2019, 30,170-184. [CrossRef]`
│   inner_content: `Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J. __Vitamin D__ and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN 2019, 30,170-184. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J. `
│   │   inner_content: `Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN 2019, 30,170-184. `
│   │   inner_content: ` and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN 2019, 30,170-184. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Zhang, Y.; Fang, F.; Tang, J.; Jia, L.; Feng, Y.; Xu, P.; Faramand, A. Association between __Vitamin D__ supplementation and mortality: Systematic review and meta-analysis. BMJ 2019, 366, l4673. [CrossRef] [PubMed]`
│   inner_content: `Zhang, Y.; Fang, F.; Tang, J.; Jia, L.; Feng, Y.; Xu, P.; Faramand, A. Association between __Vitamin D__ supplementation and mortality: Systematic review and meta-analysis. BMJ 2019, 366, l4673. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zhang, Y.; Fang, F.; Tang, J.; Jia, L.; Feng, Y.; Xu, P.; Faramand, A. Association between `
│   │   inner_content: `Zhang, Y.; Fang, F.; Tang, J.; Jia, L.; Feng, Y.; Xu, P.; Faramand, A. Association between `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` supplementation and mortality: Systematic review and meta-analysis. BMJ 2019, 366, l4673. `
│   │   inner_content: ` supplementation and mortality: Systematic review and meta-analysis. BMJ 2019, 366, l4673. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Muñoz, A.; Grant, W.B. __Vitamin D__ and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022, 14,1448. [CrossRef] [PubMed]`
│   inner_content: `Muñoz, A.; Grant, W.B. __Vitamin D__ and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022, 14,1448. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Muñoz, A.; Grant, W.B. `
│   │   inner_content: `Muñoz, A.; Grant, W.B. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022, 14,1448. `
│   │   inner_content: ` and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022, 14,1448. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Ng, K.; Nimeiri, H.S.; McCleary, N.J.; Abrams, T.A.; Yurgelun, M.B.; Cleary, J.M.; Rubinson, D.A.; Schrag, D.; Miksad, R.; Bullock, A.J. Effect of high-dose vs standard-dose __Vitamin D__3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA 2019, 321,1370-1379. [CrossRef]`
│   inner_content: `Ng, K.; Nimeiri, H.S.; McCleary, N.J.; Abrams, T.A.; Yurgelun, M.B.; Cleary, J.M.; Rubinson, D.A.; Schrag, D.; Miksad, R.; Bullock, A.J. Effect of high-dose vs standard-dose __Vitamin D__3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA 2019, 321,1370-1379. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ng, K.; Nimeiri, H.S.; McCleary, N.J.; Abrams, T.A.; Yurgelun, M.B.; Cleary, J.M.; Rubinson, D.A.; Schrag, D.; Miksad, R.; Bullock, A.J. Effect of high-dose vs standard-dose `
│   │   inner_content: `Ng, K.; Nimeiri, H.S.; McCleary, N.J.; Abrams, T.A.; Yurgelun, M.B.; Cleary, J.M.; Rubinson, D.A.; Schrag, D.; Miksad, R.; Bullock, A.J. Effect of high-dose vs standard-dose `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA 2019, 321,1370-1379. `
│   │   inner_content: `3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA 2019, 321,1370-1379. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Díaz, G.D.; Paraskeva, C.; Thomas, M.G.; Binderup, L.; Hague, A. Apoptosis is induced by the active metabolite of __Vitamin D__3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res. 2000, 60, 2304-2312. [PubMed]`
│   inner_content: `Díaz, G.D.; Paraskeva, C.; Thomas, M.G.; Binderup, L.; Hague, A. Apoptosis is induced by the active metabolite of __Vitamin D__3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res. 2000, 60, 2304-2312. [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Díaz, G.D.; Paraskeva, C.; Thomas, M.G.; Binderup, L.; Hague, A. Apoptosis is induced by the active metabolite of `
│   │   inner_content: `Díaz, G.D.; Paraskeva, C.; Thomas, M.G.; Binderup, L.; Hague, A. Apoptosis is induced by the active metabolite of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res. 2000, 60, 2304-2312. `
│   │   inner_content: `3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res. 2000, 60, 2304-2312. `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Feldman, D.; Krishnan, A.V.; Swami, S.; Giovannucci, E.; Feldman, B.J. The role of __Vitamin D__ in reducing cancer risk and progression. Nat. Rev. Cancer 2014,14, 342-357. [CrossRef]`
│   inner_content: `Feldman, D.; Krishnan, A.V.; Swami, S.; Giovannucci, E.; Feldman, B.J. The role of __Vitamin D__ in reducing cancer risk and progression. Nat. Rev. Cancer 2014,14, 342-357. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Feldman, D.; Krishnan, A.V.; Swami, S.; Giovannucci, E.; Feldman, B.J. The role of `
│   │   inner_content: `Feldman, D.; Krishnan, A.V.; Swami, S.; Giovannucci, E.; Feldman, B.J. The role of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` in reducing cancer risk and progression. Nat. Rev. Cancer 2014,14, 342-357. `
│   │   inner_content: ` in reducing cancer risk and progression. Nat. Rev. Cancer 2014,14, 342-357. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Mathieu, C.; Adorini, L. The coming of age of 1, 25-dihydroxy__Vitamin D__3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8,174-179. [CrossRef]`
│   inner_content: `Mathieu, C.; Adorini, L. The coming of age of 1, 25-dihydroxy__Vitamin D__3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8,174-179. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mathieu, C.; Adorini, L. The coming of age of 1, 25-dihydroxy`
│   │   inner_content: `Mathieu, C.; Adorini, L. The coming of age of 1, 25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8,174-179. `
│   │   inner_content: `3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8,174-179. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Yang, E.S.; Burnstein, K.L. __Vitamin D__ inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278, 46862-46868. [CrossRef]`
│   inner_content: `Yang, E.S.; Burnstein, K.L. __Vitamin D__ inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278, 46862-46868. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Yang, E.S.; Burnstein, K.L. `
│   │   inner_content: `Yang, E.S.; Burnstein, K.L. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278, 46862-46868. `
│   │   inner_content: ` inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278, 46862-46868. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Larriba, M.J.; García de Herreros, A.; Muñoz, A. __Vitamin D__ and the epithelial to mesenchymal transition. Stem Cells lnt. 2016, 2016, 6213872. [CrossRef]`
│   inner_content: `Larriba, M.J.; García de Herreros, A.; Muñoz, A. __Vitamin D__ and the epithelial to mesenchymal transition. Stem Cells lnt. 2016, 2016, 6213872. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Larriba, M.J.; García de Herreros, A.; Muñoz, A. `
│   │   inner_content: `Larriba, M.J.; García de Herreros, A.; Muñoz, A. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` and the epithelial to mesenchymal transition. Stem Cells lnt. 2016, 2016, 6213872. `
│   │   inner_content: ` and the epithelial to mesenchymal transition. Stem Cells lnt. 2016, 2016, 6213872. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Bernardi, R.J.; Johnson, C.S.; Modzelewski, R.A.; Trump, D.L. Antiproliferative effects of 1a, 25-dihydroxy__Vitamin D__3 and __Vitamin D__ analogs on tumor-derived endothelial cells. Endocrinology 2002,143, 2508-2514. [CrossRef]`
│   inner_content: `Bernardi, R.J.; Johnson, C.S.; Modzelewski, R.A.; Trump, D.L. Antiproliferative effects of 1a, 25-dihydroxy__Vitamin D__3 and __Vitamin D__ analogs on tumor-derived endothelial cells. Endocrinology 2002,143, 2508-2514. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bernardi, R.J.; Johnson, C.S.; Modzelewski, R.A.; Trump, D.L. Antiproliferative effects of 1a, 25-dihydroxy`
│   │   inner_content: `Bernardi, R.J.; Johnson, C.S.; Modzelewski, R.A.; Trump, D.L. Antiproliferative effects of 1a, 25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 and `
│   │   inner_content: `3 and `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` analogs on tumor-derived endothelial cells. Endocrinology 2002,143, 2508-2514. `
│   │   inner_content: ` analogs on tumor-derived endothelial cells. Endocrinology 2002,143, 2508-2514. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Ng, K.; Meyerhardt, J.A.; Wu, K.; Feskanich, D.; Hollis, B.W.; Giovannucci, E.L.; Fuchs, C.S. Circulating 25-hydroxy__Vitamin D__ levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 2984-2991. [CrossRef]`
│   inner_content: `Ng, K.; Meyerhardt, J.A.; Wu, K.; Feskanich, D.; Hollis, B.W.; Giovannucci, E.L.; Fuchs, C.S. Circulating 25-hydroxy__Vitamin D__ levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 2984-2991. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ng, K.; Meyerhardt, J.A.; Wu, K.; Feskanich, D.; Hollis, B.W.; Giovannucci, E.L.; Fuchs, C.S. Circulating 25-hydroxy`
│   │   inner_content: `Ng, K.; Meyerhardt, J.A.; Wu, K.; Feskanich, D.; Hollis, B.W.; Giovannucci, E.L.; Fuchs, C.S. Circulating 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 2984-2991. `
│   │   inner_content: ` levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 2984-2991. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Johansson, H.; Spadola, G.; Tosti, G.; Mandalà, M.; Minisini, A.M.; Queirolo, P.; Aristarco, V.; Baldini, F.; Cocorocchio, E.; Albertazzi, E. __Vitamin D__ supplementation and disease-free survival in stage II melanoma: A randomized placebo controlled trial. Nutrients 2021,13,1931. [CrossRef] [PubMed]`
│   inner_content: `Johansson, H.; Spadola, G.; Tosti, G.; Mandalà, M.; Minisini, A.M.; Queirolo, P.; Aristarco, V.; Baldini, F.; Cocorocchio, E.; Albertazzi, E. __Vitamin D__ supplementation and disease-free survival in stage II melanoma: A randomized placebo controlled trial. Nutrients 2021,13,1931. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Johansson, H.; Spadola, G.; Tosti, G.; Mandalà, M.; Minisini, A.M.; Queirolo, P.; Aristarco, V.; Baldini, F.; Cocorocchio, E.; Albertazzi, E. `
│   │   inner_content: `Johansson, H.; Spadola, G.; Tosti, G.; Mandalà, M.; Minisini, A.M.; Queirolo, P.; Aristarco, V.; Baldini, F.; Cocorocchio, E.; Albertazzi, E. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` supplementation and disease-free survival in stage II melanoma: A randomized placebo controlled trial. Nutrients 2021,13,1931. `
│   │   inner_content: ` supplementation and disease-free survival in stage II melanoma: A randomized placebo controlled trial. Nutrients 2021,13,1931. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Yuan, C.; Sato, K.; Hollis, B.W.; Zhang, S.; Niedzwiecki, D.; Ou, F.-S.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F.; Lenz, H.-J. Plasma 25-hydroxy__Vitamin D__ levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin. Cancer Res. 2019, 25,7497-7505. [CrossRef] [PubMed]`
│   inner_content: `Yuan, C.; Sato, K.; Hollis, B.W.; Zhang, S.; Niedzwiecki, D.; Ou, F.-S.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F.; Lenz, H.-J. Plasma 25-hydroxy__Vitamin D__ levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin. Cancer Res. 2019, 25,7497-7505. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Yuan, C.; Sato, K.; Hollis, B.W.; Zhang, S.; Niedzwiecki, D.; Ou, F.-S.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F.; Lenz, H.-J. Plasma 25-hydroxy`
│   │   inner_content: `Yuan, C.; Sato, K.; Hollis, B.W.; Zhang, S.; Niedzwiecki, D.; Ou, F.-S.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F.; Lenz, H.-J. Plasma 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin. Cancer Res. 2019, 25,7497-7505. `
│   │   inner_content: ` levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin. Cancer Res. 2019, 25,7497-7505. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Mezawa, H.; Sugiura, T.; Watanabe, M.; Norizoe, C.; Takahashi, D.; Shimojima, A.; Tamez, S.; Tsutsumi, Y.; Yanaga, K.; Urashima, M. Serum __Vitamin D__ levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer 2010,10, 347. [CrossRef] [PubMed]`
│   inner_content: `Mezawa, H.; Sugiura, T.; Watanabe, M.; Norizoe, C.; Takahashi, D.; Shimojima, A.; Tamez, S.; Tsutsumi, Y.; Yanaga, K.; Urashima, M. Serum __Vitamin D__ levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer 2010,10, 347. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mezawa, H.; Sugiura, T.; Watanabe, M.; Norizoe, C.; Takahashi, D.; Shimojima, A.; Tamez, S.; Tsutsumi, Y.; Yanaga, K.; Urashima, M. Serum `
│   │   inner_content: `Mezawa, H.; Sugiura, T.; Watanabe, M.; Norizoe, C.; Takahashi, D.; Shimojima, A.; Tamez, S.; Tsutsumi, Y.; Yanaga, K.; Urashima, M. Serum `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer 2010,10, 347. `
│   │   inner_content: ` levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer 2010,10, 347. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma __Vitamin D__ concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol. 2014, 32, 2430-2439. [CrossRef]`
│   inner_content: `Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma __Vitamin D__ concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol. 2014, 32, 2430-2439. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma `
│   │   inner_content: `Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol. 2014, 32, 2430-2439. `
│   │   inner_content: ` concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol. 2014, 32, 2430-2439. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Toriola, A.T.; Nguyen, N.; Scheitler-Ring, K.; Colditz, G.A. Circulating 25-hydroxy__Vitamin D__ levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol. Biomark. Prev. 2014, 23, 917-933. [CrossRef]`
│   inner_content: `Toriola, A.T.; Nguyen, N.; Scheitler-Ring, K.; Colditz, G.A. Circulating 25-hydroxy__Vitamin D__ levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol. Biomark. Prev. 2014, 23, 917-933. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Toriola, A.T.; Nguyen, N.; Scheitler-Ring, K.; Colditz, G.A. Circulating 25-hydroxy`
│   │   inner_content: `Toriola, A.T.; Nguyen, N.; Scheitler-Ring, K.; Colditz, G.A. Circulating 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol. Biomark. Prev. 2014, 23, 917-933. `
│   │   inner_content: ` levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol. Biomark. Prev. 2014, 23, 917-933. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxy__Vitamin D__ and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012, 23, 363-370. [CrossRef]`
│   inner_content: `Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxy__Vitamin D__ and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012, 23, 363-370. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxy`
│   │   inner_content: `Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012, 23, 363-370. `
│   │   inner_content: ` and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012, 23, 363-370. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Chen, Q.-Y.; Kim, S.; Lee, B.; Jeong, G.; Lee, D.H.; Keum, N.; Manson, J.E.; Giovannucci, E.L. Post-diagnosis __Vitamin D__ supplement use and survival among cancer patients: A meta-analysis. Nutrients 2022,14, 3418. [CrossRef]`
│   inner_content: `Chen, Q.-Y.; Kim, S.; Lee, B.; Jeong, G.; Lee, D.H.; Keum, N.; Manson, J.E.; Giovannucci, E.L. Post-diagnosis __Vitamin D__ supplement use and survival among cancer patients: A meta-analysis. Nutrients 2022,14, 3418. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chen, Q.-Y.; Kim, S.; Lee, B.; Jeong, G.; Lee, D.H.; Keum, N.; Manson, J.E.; Giovannucci, E.L. Post-diagnosis `
│   │   inner_content: `Chen, Q.-Y.; Kim, S.; Lee, B.; Jeong, G.; Lee, D.H.; Keum, N.; Manson, J.E.; Giovannucci, E.L. Post-diagnosis `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` supplement use and survival among cancer patients: A meta-analysis. Nutrients 2022,14, 3418. `
│   │   inner_content: ` supplement use and survival among cancer patients: A meta-analysis. Nutrients 2022,14, 3418. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vaughan-Shaw, P.G.; Buijs, L.F.; Blackmur, J.P.; Theodoratou, E.; Zgaga, L.; Din, F.V.N.; Farrington, S.M.; Dunlop, M.G. The effect of __Vitamin D__ supplementation on survival in patients with colorectal cancer: Systematic review and meta-analysis of randomised controlled trials. Br. J. Cancer 2020,123,1705-1712. [CrossRef]`
│   inner_content: `Vaughan-Shaw, P.G.; Buijs, L.F.; Blackmur, J.P.; Theodoratou, E.; Zgaga, L.; Din, F.V.N.; Farrington, S.M.; Dunlop, M.G. The effect of __Vitamin D__ supplementation on survival in patients with colorectal cancer: Systematic review and meta-analysis of randomised controlled trials. Br. J. Cancer 2020,123,1705-1712. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vaughan-Shaw, P.G.; Buijs, L.F.; Blackmur, J.P.; Theodoratou, E.; Zgaga, L.; Din, F.V.N.; Farrington, S.M.; Dunlop, M.G. The effect of `
│   │   inner_content: `Vaughan-Shaw, P.G.; Buijs, L.F.; Blackmur, J.P.; Theodoratou, E.; Zgaga, L.; Din, F.V.N.; Farrington, S.M.; Dunlop, M.G. The effect of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` supplementation on survival in patients with colorectal cancer: Systematic review and meta-analysis of randomised controlled trials. Br. J. Cancer 2020,123,1705-1712. `
│   │   inner_content: ` supplementation on survival in patients with colorectal cancer: Systematic review and meta-analysis of randomised controlled trials. Br. J. Cancer 2020,123,1705-1712. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Kuznia, S.; Zhu, A.; Akutsu, T.; Buring, J.E.; Camargo, C.A., Jr.; Cook, N.R.; Chen, L.-J.; Cheng, T.-Y.D.; Hantunen, S.; Lee, I.M. Efficacy of __Vitamin D__3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res. Rev. 2023, 87,101923. [CrossRef]`
│   inner_content: `Kuznia, S.; Zhu, A.; Akutsu, T.; Buring, J.E.; Camargo, C.A., Jr.; Cook, N.R.; Chen, L.-J.; Cheng, T.-Y.D.; Hantunen, S.; Lee, I.M. Efficacy of __Vitamin D__3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res. Rev. 2023, 87,101923. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kuznia, S.; Zhu, A.; Akutsu, T.; Buring, J.E.; Camargo, C.A., Jr.; Cook, N.R.; Chen, L.-J.; Cheng, T.-Y.D.; Hantunen, S.; Lee, I.M. Efficacy of `
│   │   inner_content: `Kuznia, S.; Zhu, A.; Akutsu, T.; Buring, J.E.; Camargo, C.A., Jr.; Cook, N.R.; Chen, L.-J.; Cheng, T.-Y.D.; Hantunen, S.; Lee, I.M. Efficacy of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res. Rev. 2023, 87,101923. `
│   │   inner_content: `3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res. Rev. 2023, 87,101923. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Wang, L.; Wang, C.; Wang, J.; Huang, X.; Cheng, Y. Longitudinal, observational study on associations between postoperative nutritional __Vitamin D__ supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci. Rep. 2016, 6, 38962. [CrossRef]`
│   inner_content: `Wang, L.; Wang, C.; Wang, J.; Huang, X.; Cheng, Y. Longitudinal, observational study on associations between postoperative nutritional __Vitamin D__ supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci. Rep. 2016, 6, 38962. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wang, L.; Wang, C.; Wang, J.; Huang, X.; Cheng, Y. Longitudinal, observational study on associations between postoperative nutritional `
│   │   inner_content: `Wang, L.; Wang, C.; Wang, J.; Huang, X.; Cheng, Y. Longitudinal, observational study on associations between postoperative nutritional `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci. Rep. 2016, 6, 38962. `
│   │   inner_content: ` supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci. Rep. 2016, 6, 38962. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Madden, J.M.; Murphy, L.; Zgaga, L.; Bennett, K. De novo __Vitamin D__ supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res. Treat. 2018,172,179-190. [CrossRef] [PubMed]`
│   inner_content: `Madden, J.M.; Murphy, L.; Zgaga, L.; Bennett, K. De novo __Vitamin D__ supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res. Treat. 2018,172,179-190. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Madden, J.M.; Murphy, L.; Zgaga, L.; Bennett, K. De novo `
│   │   inner_content: `Madden, J.M.; Murphy, L.; Zgaga, L.; Bennett, K. De novo `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res. Treat. 2018,172,179-190. `
│   │   inner_content: ` supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res. Treat. 2018,172,179-190. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Marshall, D.T.; Savage, S.J.; Garrett-Mayer, E.; Keane, T.E.; Hollis, B.W.; Horst, R.L.; Ambrose, L.H.; Kindy, M.S.; Gattoni-Celli, S. __Vitamin D__3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J. Clin. Endocrinol. Metab. 2012, 97, 2315-2324. [CrossRef] [PubMed]`
│   inner_content: `Marshall, D.T.; Savage, S.J.; Garrett-Mayer, E.; Keane, T.E.; Hollis, B.W.; Horst, R.L.; Ambrose, L.H.; Kindy, M.S.; Gattoni-Celli, S. __Vitamin D__3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J. Clin. Endocrinol. Metab. 2012, 97, 2315-2324. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Marshall, D.T.; Savage, S.J.; Garrett-Mayer, E.; Keane, T.E.; Hollis, B.W.; Horst, R.L.; Ambrose, L.H.; Kindy, M.S.; Gattoni-Celli, S. `
│   │   inner_content: `Marshall, D.T.; Savage, S.J.; Garrett-Mayer, E.; Keane, T.E.; Hollis, B.W.; Horst, R.L.; Ambrose, L.H.; Kindy, M.S.; Gattoni-Celli, S. `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J. Clin. Endocrinol. Metab. 2012, 97, 2315-2324. `
│   │   inner_content: `3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J. Clin. Endocrinol. Metab. 2012, 97, 2315-2324. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Wagner, D.; Trudel, D.; Van der Kwast, T.; Nonn, L.; Giangreco, A.A.; Li, D.; Dias, A.; Cardoza, M.; Laszlo, S.; Hersey, K. Randomized clinical trial of __Vitamin D__3 doses on prostatic __Vitamin D__ metabolite levels and ki67 labeling in prostate cancer patients. J. Clin. Endocrinol. Metab. 2013, 98,1498-1507. [CrossRef] [PubMed]`
│   inner_content: `Wagner, D.; Trudel, D.; Van der Kwast, T.; Nonn, L.; Giangreco, A.A.; Li, D.; Dias, A.; Cardoza, M.; Laszlo, S.; Hersey, K. Randomized clinical trial of __Vitamin D__3 doses on prostatic __Vitamin D__ metabolite levels and ki67 labeling in prostate cancer patients. J. Clin. Endocrinol. Metab. 2013, 98,1498-1507. [CrossRef] [PubMed]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wagner, D.; Trudel, D.; Van der Kwast, T.; Nonn, L.; Giangreco, A.A.; Li, D.; Dias, A.; Cardoza, M.; Laszlo, S.; Hersey, K. Randomized clinical trial of `
│   │   inner_content: `Wagner, D.; Trudel, D.; Van der Kwast, T.; Nonn, L.; Giangreco, A.A.; Li, D.; Dias, A.; Cardoza, M.; Laszlo, S.; Hersey, K. Randomized clinical trial of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 doses on prostatic `
│   │   inner_content: `3 doses on prostatic `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` metabolite levels and ki67 labeling in prostate cancer patients. J. Clin. Endocrinol. Metab. 2013, 98,1498-1507. `
│   │   inner_content: ` metabolite levels and ki67 labeling in prostate cancer patients. J. Clin. Endocrinol. Metab. 2013, 98,1498-1507. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[PubMed]`
│   │   inner_content: `PubMed`
│   │   url: `PubMed`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PubMed`
│   │   │   inner_content: `PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Zeichner, S.B.; Koru-Sengul, T.; Shah, N.; Liu, Q.; Markward, N.J.; Montero, A.J.; Glück, S.; Silva, O.; Ahn, E.R. Improved clinical outcomes associated with __Vitamin D__ supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin. Breast Cancer 2015,15, e1-e11. [CrossRef]`
│   inner_content: `Zeichner, S.B.; Koru-Sengul, T.; Shah, N.; Liu, Q.; Markward, N.J.; Montero, A.J.; Glück, S.; Silva, O.; Ahn, E.R. Improved clinical outcomes associated with __Vitamin D__ supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin. Breast Cancer 2015,15, e1-e11. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zeichner, S.B.; Koru-Sengul, T.; Shah, N.; Liu, Q.; Markward, N.J.; Montero, A.J.; Glück, S.; Silva, O.; Ahn, E.R. Improved clinical outcomes associated with `
│   │   inner_content: `Zeichner, S.B.; Koru-Sengul, T.; Shah, N.; Liu, Q.; Markward, N.J.; Montero, A.J.; Glück, S.; Silva, O.; Ahn, E.R. Improved clinical outcomes associated with `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin. Breast Cancer 2015,15, e1-e11. `
│   │   inner_content: ` supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin. Breast Cancer 2015,15, e1-e11. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Amon, U.; Yaguboglu, R.; Ennis, M.; Holick, M.F.; Amon, J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of __Vitamin D__3 According to the &quot;Coimbra Protocol&quot;. Nutrients 2022,14,1575. [CrossRef]`
│   inner_content: `Amon, U.; Yaguboglu, R.; Ennis, M.; Holick, M.F.; Amon, J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of __Vitamin D__3 According to the &quot;Coimbra Protocol&quot;. Nutrients 2022,14,1575. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Amon, U.; Yaguboglu, R.; Ennis, M.; Holick, M.F.; Amon, J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of `
│   │   inner_content: `Amon, U.; Yaguboglu, R.; Ennis, M.; Holick, M.F.; Amon, J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: `3 According to the &quot;Coimbra Protocol&quot;. Nutrients 2022,14,1575. `
│   │   inner_content: `3 According to the &quot;Coimbra Protocol&quot;. Nutrients 2022,14,1575. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Finamor, D.C.; Sinigaglia-Coimbra, R.; Neves, L.C.M.; Gutierrez, M.; Silva, J.J.; Torres, L.D.; Surano, F.; Neto, D.J.; Novo, N.F.; Juliano, Y. A pilot study assessing the effect of prolonged administration of high daily doses of __Vitamin D__ on the clinical course of vitiligo and psoriasis. Derm.-Endocrinol. 2013, 5, 222-234. [CrossRef]`
│   inner_content: `Finamor, D.C.; Sinigaglia-Coimbra, R.; Neves, L.C.M.; Gutierrez, M.; Silva, J.J.; Torres, L.D.; Surano, F.; Neto, D.J.; Novo, N.F.; Juliano, Y. A pilot study assessing the effect of prolonged administration of high daily doses of __Vitamin D__ on the clinical course of vitiligo and psoriasis. Derm.-Endocrinol. 2013, 5, 222-234. [CrossRef]`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Finamor, D.C.; Sinigaglia-Coimbra, R.; Neves, L.C.M.; Gutierrez, M.; Silva, J.J.; Torres, L.D.; Surano, F.; Neto, D.J.; Novo, N.F.; Juliano, Y. A pilot study assessing the effect of prolonged administration of high daily doses of `
│   │   inner_content: `Finamor, D.C.; Sinigaglia-Coimbra, R.; Neves, L.C.M.; Gutierrez, M.; Silva, J.J.; Torres, L.D.; Surano, F.; Neto, D.J.; Novo, N.F.; Juliano, Y. A pilot study assessing the effect of prolonged administration of high daily doses of `
│   ├── BoldNode
│   │   full_match: `__Vitamin D__`
│   │   inner_content: `Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D`
│   │   │   inner_content: `Vitamin D`
│   ├── TextNode
│   │   full_match: ` on the clinical course of vitiligo and psoriasis. Derm.-Endocrinol. 2013, 5, 222-234. `
│   │   inner_content: ` on the clinical course of vitiligo and psoriasis. Derm.-Endocrinol. 2013, 5, 222-234. `
│   ├── LinkNode
│   │   full_match: `[CrossRef]`
│   │   inner_content: `CrossRef`
│   │   url: `CrossRef`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CrossRef`
│   │   │   inner_content: `CrossRef`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Cancer)) category contains:`
│   inner_content: `VitaminDWiki – ((Cancer)) category contains:`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Cancer))`
│   │   inner_content: `Cancer`
│   │   page: `Cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Cancer`
│   │   │   inner_content: `Cancer`
│   ├── TextNode
│   │   full_match: ` category contains:`
│   │   inner_content: ` category contains:`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Cancer&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Cancer&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Cancer
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!~~#F00:87 ~~Meta-analyses  in VitaminDWiki with CANCER etc in the title`
│   inner_content: `~~#F00:87 ~~Meta-analyses  in VitaminDWiki with CANCER etc in the title`
│   level: `4`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#F00:87 ~~`
│   │   inner_content: `87 `
│   │   attrs_dict:
│   │   │   raw_content: #F00
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `87 `
│   │   │   inner_content: `87 `
│   ├── TextNode
│   │   full_match: `Meta-analyses  in VitaminDWiki with CANCER etc in the title`
│   │   inner_content: `Meta-analyses  in VitaminDWiki with CANCER etc in the title`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;This list is automatically updated&#39;&#39;`
│   inner_content: `This list is automatically updated`
│   children:
│   ├── TextNode
│   │   full_match: `This list is automatically updated`
│   │   inner_content: `This list is automatically updated`├── TextNode
│   full_match: `\n{LIST()}\n{list max=&quot;100&quot;}\n`
│   inner_content: `\n{LIST()}\n{list max=&quot;100&quot;}\n`├── FilterNode
│   full_match: `{filter categories=&quot;82&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: categories=&quot;82&quot;
│   │   categories: 82├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── FilterNode
│   full_match: `{filter field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;
│   │   field: title
│   │   content: Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── FilterNode
│   full_match: `{filter type=&quot;wiki page&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: type=&quot;wiki page&quot;
│   │   type: wiki page├── TextNode
│   full_match: `\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`
│   inner_content: `\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!~~#F06:5+~~  VitaminDWiki LOADING DOSE pages with CANCER etc in title`
│   inner_content: `~~#F06:5+~~  VitaminDWiki LOADING DOSE pages with CANCER etc in title`
│   level: `4`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#F06:5+~~`
│   │   inner_content: `5+`
│   │   attrs_dict:
│   │   │   raw_content: #F06
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `5+`
│   │   │   inner_content: `5+`
│   ├── TextNode
│   │   full_match: `  VitaminDWiki LOADING DOSE pages with CANCER etc in title`
│   │   inner_content: `  VitaminDWiki LOADING DOSE pages with CANCER etc in title`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;This list is automatically updated&#39;&#39;`
│   inner_content: `This list is automatically updated`
│   children:
│   ├── TextNode
│   │   full_match: `This list is automatically updated`
│   │   inner_content: `This list is automatically updated`├── TextNode
│   full_match: `\n{LIST()}\n{list max=&quot;50&quot;}\n`
│   inner_content: `\n{LIST()}\n{list max=&quot;50&quot;}\n`├── FilterNode
│   full_match: `{filter categories=&quot;73&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: categories=&quot;73&quot;
│   │   categories: 73├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── FilterNode
│   full_match: `{filter field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;
│   │   field: title
│   │   content: Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── FilterNode
│   full_match: `{filter type=&quot;wiki page&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: type=&quot;wiki page&quot;
│   │   type: wiki page├── TextNode
│   full_match: `\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`
│   inner_content: `\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!~~#F06:726+~~  VitaminDWiki pages have both CANCER  AND VITAMIN  in the title`
│   inner_content: `~~#F06:726+~~  VitaminDWiki pages have both CANCER  AND VITAMIN  in the title`
│   level: `4`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#F06:726+~~`
│   │   inner_content: `726+`
│   │   attrs_dict:
│   │   │   raw_content: #F06
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `726+`
│   │   │   inner_content: `726+`
│   ├── TextNode
│   │   full_match: `  VitaminDWiki pages have both CANCER  AND VITAMIN  in the title`
│   │   inner_content: `  VitaminDWiki pages have both CANCER  AND VITAMIN  in the title`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;This list is automatically updated&#39;&#39;`
│   inner_content: `This list is automatically updated`
│   children:
│   ├── TextNode
│   │   full_match: `This list is automatically updated`
│   │   inner_content: `This list is automatically updated`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;__Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.__&#39;&#39;`
│   inner_content: `__Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.__`
│   children:
│   ├── BoldNode
│   │   full_match: `__Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.__`
│   │   inner_content: `Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.`
│   │   │   inner_content: `Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.`├── TextNode
│   full_match: `\n{LIST()}\n  `
│   inner_content: `\n{LIST()}\n  `├── FilterNode
│   full_match: `{filter type=&quot;wiki page&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: type=&quot;wiki page&quot;
│   │   type: wiki page├── TextNode
│   full_match: `\n  {list max=&quot;1000&quot;}\n  `
│   inner_content: `\n  {list max=&quot;1000&quot;}\n  `├── FilterNode
│   full_match: `{filter field=&quot;title&quot; content=&quot;cancer AND Vitamin&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: field=&quot;title&quot; content=&quot;cancer AND Vitamin&quot;
│   │   field: title
│   │   content: cancer AND Vitamin├── TextNode
│   full_match: `\n  `
│   inner_content: `\n  `├── FilterNode
│   full_match: `{filter field=&quot;title&quot; content=&quot;NOT \&quot; K2\&quot;&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: field=&quot;title&quot; content=&quot;NOT \&quot; K2\&quot;&quot;
│   │   field: title
│   │   content: NOT \├── TextNode
│   full_match: `\n  {sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`
│   inner_content: `\n  {sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!600,000 Hits for (cancer metabolism) &quot;vitamin d&quot; in Google Scholar Oct 2023`
│   inner_content: `600,000 Hits for (cancer metabolism) &quot;vitamin d&quot; in Google Scholar Oct 2023`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `600,000 Hits for (cancer metabolism) &quot;vitamin d&quot; in Google Scholar Oct 2023`
│   │   inner_content: `600,000 Hits for (cancer metabolism) &quot;vitamin d&quot; in Google Scholar Oct 2023`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__[https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C48&amp;q=%28cancer+metabolism%29+%22vitamin+d%22&amp;btnG=|Google Scholar]__`
│   inner_content: `[https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C48&amp;q=%28cancer+metabolism%29+%22vitamin+d%22&amp;btnG=|Google Scholar]`
│   children:
│   ├── LinkNode
│   │   full_match: `[https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C48&amp;q=%28cancer+metabolism%29+%22vitamin+d%22&amp;btnG=|Google Scholar]`
│   │   inner_content: `Google Scholar`
│   │   url: `https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C48&amp;q=%28cancer+metabolism%29+%22vitamin+d%22&amp;btnG=`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Google Scholar`
│   │   │   inner_content: `Google Scholar`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `* An update on vitamin D signaling and cancer - February 2022 https://doi.org/10.1016/j.semcancer.2020.05.018  FREE PDF`
│   inner_content: ` An update on vitamin D signaling and cancer - February 2022 https://doi.org/10.1016/j.semcancer.2020.05.018  FREE PDF`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: ` An update on vitamin D signaling and cancer - February 2022 https://doi.org/10.1016/j.semcancer.2020.05.018  FREE PDF`
│   │   inner_content: ` An update on vitamin D signaling and cancer - February 2022 https://doi.org/10.1016/j.semcancer.2020.05.018  FREE PDF`├── TextNode
│   full_match: `\n * Vitamin D and the risk for cancer: A molecular analysis - Feb 2022 https://doi.org/10.1016/j.bcp.2021.114735 FREE PDF\n * New insights into molecules and pathways of cancer metabolism and therapeutic implications - Nov 2020 https://doi.org/10.1002/cac2.12112 FREE PDF\n *Relationship Between Vitamin D Supplementation and Improvement in Body for Carcinogenesis: A Literature Review 2022 - https://doi.org/10.37275/bsm.v6i2.447 FREE PDF\n`
│   inner_content: `\n * Vitamin D and the risk for cancer: A molecular analysis - Feb 2022 https://doi.org/10.1016/j.bcp.2021.114735 FREE PDF\n * New insights into molecules and pathways of cancer metabolism and therapeutic implications - Nov 2020 https://doi.org/10.1002/cac2.12112 FREE PDF\n *Relationship Between Vitamin D Supplementation and Improvement in Body for Carcinogenesis: A Literature Review 2022 - https://doi.org/10.37275/bsm.v6i2.447 FREE PDF\n`├── ListItemNode
│   full_match: `* Metabolism and Colorectal Cancer - Jan 2023 https://doi.org/10.1146/annurev-pathmechdis-031521-041113 FREE PDF`
│   inner_content: ` Metabolism and Colorectal Cancer - Jan 2023 https://doi.org/10.1146/annurev-pathmechdis-031521-041113 FREE PDF`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: ` Metabolism and Colorectal Cancer - Jan 2023 https://doi.org/10.1146/annurev-pathmechdis-031521-041113 FREE PDF`
│   │   inner_content: ` Metabolism and Colorectal Cancer - Jan 2023 https://doi.org/10.1146/annurev-pathmechdis-031521-041113 FREE PDF`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!Cancer Metabolism as a Therapeutic Target and Review of Interventions
 Nutrients 2023, 15, 4245. https://doi.org/10.3390/ nu15194245
Matthew T. J. Halma 1,2 , Jack A. Tuszynski3,4,5 and Paul E. Marik ^*
Department of Physics and Astronomy, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands
EbMC Squared CIC, Bath BA2 4BL, UK
Department of Physics, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB T6G 2M9, Canada
Department of Data Science and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland
DIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, I-1029 Turin, Italy
Frontline COVID-19 Critical Care Alliance, Washington, DC 20036, USA * Correspondence: pmarik@flccc.net

{img type=&quot;attId&quot; attId=&quot;20157&quot; width=&quot;800&quot;}
Cancer is amenable to low-cost treatments, given that it has a significant metabolic com­ponent, which can be affected through diet and lifestyle change at minimal cost. The Warburg hypothesis states that cancer cells have an altered cell metabolism towards anaerobic glycolysis. Given this metabolic reprogramming in cancer cells, it is possible to target cancers metabolically by depriving them of glucose. In addition to dietary and lifestyle modifications which work on tumors metabolically, there are a panoply of nutritional supplements and repurposed drugs associated with cancer prevention and better treatment outcomes. These interventions and their evidentiary basis are covered in the latter half of this review to guide future cancer treatment.

!!!!!Recommended: Vitamin D (Extracted from PDF)
Vitamin D is synthesized in the human skin through the influence of UV B radiation and is then converted into the active form, 1,25-dihydroxyvitamin D3 (calcitriol), in the kidney [323-325]. 25-hydroxyvitamin D3 (25(OH)D3) is considered the best indicator of vitamin D status, with a level &gt; 30 ng/mL considered normal, 20-30 ng/mL considered insufficient, and &lt;20 ng/mL considered deficient [324-326]. Recent data suggest that a level &gt; 50 ng/mL is desirable, and, ideally, targeting a level between 55 and 90 ng/mL is preferable [323,327-329]. Adequate vitamin D supplementation is important to achieve optimal levels in patients with low vitamin D levels, and using 50,000 IU D3 capsules in divided doses over a few days is recommended [323,328,329] (Supplementary Table S1).
Vitamin D plays a critical role in various physiological pathways, including energy metabolism, immunity, and cellular growth [330]. It has pleiotropic functions and regulates over 1200 genes within the human genome, with a significant role in the modulation of the immune system [323,331,332]. Observational and randomized controlled studies indicate that a low vitamin D status is associated with higher mortality from conditions like cancer and cardiovascular disease [333,334]. Vitamin D deficiency increases the risk of breast, colon, prostate, and other cancers, while supplemental vitamin D intake has an inverse relationship with cancer risk [324,335]. Higher latitudes are associated with increased risk of vitamin D deficiency and various cancers, with vitamin D supplementation likely playing a crucial role in cancer prevention [324,336]. Achieving a vitamin D level of 80 ng/mL may reduce cancer incidence rates by 70% [337].
__Mechanism__
Vitamin D exhibits diverse antineoplastic activity through various pathways. It binds to the vitamin D receptor and induces differentiation and apoptosis; it also inhibits cancer stem cells, proliferation, angiogenesis, and metastatic potential [338]. It promotes apoptosis of cancer cells, inhibits WNT-p catenin signaling, and has anti-inflammatory effects by downregulating nuclear factor-Kp and inhibiting cyclooxygenase expression [339-341]. Vitamin D also regulates cell cycle, growth factor pathways, and immune responses against tumor cells [337,342]. It triggers autophagic death, promotes cell differentiation, and exhibits anti-angiogenic effects [337,343,344]. These mechanisms collectively contribute to vitamin D&#39;s anticancer effects and may help reduce cancer incidence and mortality [336].
__Clinical Evidence__
Multiple studies indicate that a significant proportion of cancer patients are vitamin D-deficient (level &lt; 20 ng/mL) and that higher plasma 25-hydroxyvitamin D levels are associated with improved survival in colorectal, breast, gastric, and lymphoma cancer patients [334,338,345-351]. Meta-analyses and clinical trials demonstrate that vitamin D supplementation may reduce cancer mortality and improve survival in cancer patients, especially when used in combination with chemotherapy [352-358]. SUNSHINE, a clinical trial on metastatic colorectal cancer patients, showed that “high-dose&quot; vitamin D3 (aiming for a level of &gt;50 ng/mL) combined with standard chemotherapy resulted in improved progression-free survival compared to standard-dose vitamin D3 [338]. Adequate vitamin D dosing aiming for a level between 55 and 90 ng/mL may have additional benefits in cancer patients [338]. Vitamin D supplementation is suggested to have additive or synergistic effects when combined with conventional chemotherapy [359,360].
__Dosing Recommendation__
Vitamin D supplementation is likely beneficial for most types of cancers, especially breast, colorectal, gastric, esophageal, lung, and prostate cancer, lymphomas, and melanoma. Due to the severe vitamin D deficiency observed in most cancer patients, a high loading dose of vitamin D is recommended, followed by dose titration aiming for a level of &gt;50 ng/mL (target 55-90 ng/mL). Some types of cancer may require higher levels, up to 150 ng/mL, to halt growth and metastasis. Daily doses of 20,000 to 50,000 IU/day are suggested until the desired vitamin D level is reached. It is important to monitor vitamin D levels to ensure appropriate maintenance dosing, and daily dosing of vitamin D3 is preferred over large intermittent bolus dosing. Vitamin K2 (menaquinone (MK4/MK7)) and magnesium are recommended in conjunction with high vitamin D doses (&gt;8000 IU/day). Measuring parathyroid levels and calcium levels can help titrate the vitamin D dose according to the Coimbra Protocol [65,66].
{FONT(size=&quot;22&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;20201&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
!!!!!39 Vitamin D references (of 520 references)
*Wimalawansa, S.J. Physiological Basis for Using __Vitamin D__ to Improve Health. Biomedicines 2023,11,1542. [CrossRef]
*Holick, M.F. __Vitamin D__ Deficiency. N. Engl. J. Med. 2002, 357, 266-281. [CrossRef]
*Brandi, M.L. Indications on the use of __Vitamin D__ and __Vitamin D__ metabolites in clinical phenotypes. Clin. Cases Miner. Bone Metab. 2010, 7, 243-250.
*Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, PJ. Prevalence of __Vitamin D__ Insufficiency in an Adult Normal Population. Osteoporos. lnt. 1997, 7, 439-443. [CrossRef]
*Vieth, R. Why the optimal requirement for __Vitamin D__3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579. [CrossRef]
*Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients 2022,14, 2997. [CrossRef]
*Wimalawansa, S.J. Effective and practical ways to overcome __Vitamin D__ deficiency. J. Fam. Med. Community Health 2021, 8,1185.
*Carlberg, C.; Velleuer, E. __Vitamin D__ and the risk for cancer: A molecular analysis. Biochem. Pharmacol. 2022,196,114735. [CrossRef]
*Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. __Vitamin D__: Modulator of the immune system. Curr. Opin. Pharmacol. 2010,10, 482-496. [CrossRef]
*Bartley, J. __Vitamin D__: Emerging roles in infection and immunity. Expert Rev. Anti-lnfect. Ther. 2010, 8,1359-1369. [CrossRef] [PubMed]
*Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B. __Vitamin D__ and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. [CrossRef] [PubMed]
*Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F. __Vitamin D__ status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol. 2015, 33, 3503. [CrossRef]
*Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J. __Vitamin D__ and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN 2019, 30,170-184. [CrossRef]
*Zhang, Y.; Fang, F.; Tang, J.; Jia, L.; Feng, Y.; Xu, P.; Faramand, A. Association between __Vitamin D__ supplementation and mortality: Systematic review and meta-analysis. BMJ 2019, 366, l4673. [CrossRef] [PubMed]
*Muñoz, A.; Grant, W.B. __Vitamin D__ and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022, 14,1448. [CrossRef] [PubMed]
*Ng, K.; Nimeiri, H.S.; McCleary, N.J.; Abrams, T.A.; Yurgelun, M.B.; Cleary, J.M.; Rubinson, D.A.; Schrag, D.; Miksad, R.; Bullock, A.J. Effect of high-dose vs standard-dose __Vitamin D__3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA 2019, 321,1370-1379. [CrossRef]
*Díaz, G.D.; Paraskeva, C.; Thomas, M.G.; Binderup, L.; Hague, A. Apoptosis is induced by the active metabolite of __Vitamin D__3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res. 2000, 60, 2304-2312. [PubMed]
*Feldman, D.; Krishnan, A.V.; Swami, S.; Giovannucci, E.; Feldman, B.J. The role of __Vitamin D__ in reducing cancer risk and progression. Nat. Rev. Cancer 2014,14, 342-357. [CrossRef]
*Mathieu, C.; Adorini, L. The coming of age of 1, 25-dihydroxy__Vitamin D__3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8,174-179. [CrossRef]
*Yang, E.S.; Burnstein, K.L. __Vitamin D__ inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278, 46862-46868. [CrossRef]
*Larriba, M.J.; García de Herreros, A.; Muñoz, A. __Vitamin D__ and the epithelial to mesenchymal transition. Stem Cells lnt. 2016, 2016, 6213872. [CrossRef]
*Bernardi, R.J.; Johnson, C.S.; Modzelewski, R.A.; Trump, D.L. Antiproliferative effects of 1a, 25-dihydroxy__Vitamin D__3 and __Vitamin D__ analogs on tumor-derived endothelial cells. Endocrinology 2002,143, 2508-2514. [CrossRef]
*Ng, K.; Meyerhardt, J.A.; Wu, K.; Feskanich, D.; Hollis, B.W.; Giovannucci, E.L.; Fuchs, C.S. Circulating 25-hydroxy__Vitamin D__ levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 2984-2991. [CrossRef]
*Johansson, H.; Spadola, G.; Tosti, G.; Mandalà, M.; Minisini, A.M.; Queirolo, P.; Aristarco, V.; Baldini, F.; Cocorocchio, E.; Albertazzi, E. __Vitamin D__ supplementation and disease-free survival in stage II melanoma: A randomized placebo controlled trial. Nutrients 2021,13,1931. [CrossRef] [PubMed]
*Yuan, C.; Sato, K.; Hollis, B.W.; Zhang, S.; Niedzwiecki, D.; Ou, F.-S.; Chang, I.W.; O&#39;Neil, B.H.; Innocenti, F.; Lenz, H.-J. Plasma 25-hydroxy__Vitamin D__ levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin. Cancer Res. 2019, 25,7497-7505. [CrossRef] [PubMed]
*Mezawa, H.; Sugiura, T.; Watanabe, M.; Norizoe, C.; Takahashi, D.; Shimojima, A.; Tamez, S.; Tsutsumi, Y.; Yanaga, K.; Urashima, M. Serum __Vitamin D__ levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer 2010,10, 347. [CrossRef] [PubMed]
*Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma __Vitamin D__ concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol. 2014, 32, 2430-2439. [CrossRef]
*Toriola, A.T.; Nguyen, N.; Scheitler-Ring, K.; Colditz, G.A. Circulating 25-hydroxy__Vitamin D__ levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol. Biomark. Prev. 2014, 23, 917-933. [CrossRef]
*Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxy__Vitamin D__ and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control 2012, 23, 363-370. [CrossRef]
*Chen, Q.-Y.; Kim, S.; Lee, B.; Jeong, G.; Lee, D.H.; Keum, N.; Manson, J.E.; Giovannucci, E.L. Post-diagnosis __Vitamin D__ supplement use and survival among cancer patients: A meta-analysis. Nutrients 2022,14, 3418. [CrossRef]
*Vaughan-Shaw, P.G.; Buijs, L.F.; Blackmur, J.P.; Theodoratou, E.; Zgaga, L.; Din, F.V.N.; Farrington, S.M.; Dunlop, M.G. The effect of __Vitamin D__ supplementation on survival in patients with colorectal cancer: Systematic review and meta-analysis of randomised controlled trials. Br. J. Cancer 2020,123,1705-1712. [CrossRef]
*Kuznia, S.; Zhu, A.; Akutsu, T.; Buring, J.E.; Camargo, C.A., Jr.; Cook, N.R.; Chen, L.-J.; Cheng, T.-Y.D.; Hantunen, S.; Lee, I.M. Efficacy of __Vitamin D__3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res. Rev. 2023, 87,101923. [CrossRef]
*Wang, L.; Wang, C.; Wang, J.; Huang, X.; Cheng, Y. Longitudinal, observational study on associations between postoperative nutritional __Vitamin D__ supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci. Rep. 2016, 6, 38962. [CrossRef]
*Madden, J.M.; Murphy, L.; Zgaga, L.; Bennett, K. De novo __Vitamin D__ supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res. Treat. 2018,172,179-190. [CrossRef] [PubMed]
*Marshall, D.T.; Savage, S.J.; Garrett-Mayer, E.; Keane, T.E.; Hollis, B.W.; Horst, R.L.; Ambrose, L.H.; Kindy, M.S.; Gattoni-Celli, S. __Vitamin D__3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J. Clin. Endocrinol. Metab. 2012, 97, 2315-2324. [CrossRef] [PubMed]
*Wagner, D.; Trudel, D.; Van der Kwast, T.; Nonn, L.; Giangreco, A.A.; Li, D.; Dias, A.; Cardoza, M.; Laszlo, S.; Hersey, K. Randomized clinical trial of __Vitamin D__3 doses on prostatic __Vitamin D__ metabolite levels and ki67 labeling in prostate cancer patients. J. Clin. Endocrinol. Metab. 2013, 98,1498-1507. [CrossRef] [PubMed]
*Zeichner, S.B.; Koru-Sengul, T.; Shah, N.; Liu, Q.; Markward, N.J.; Montero, A.J.; Glück, S.; Silva, O.; Ahn, E.R. Improved clinical outcomes associated with __Vitamin D__ supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin. Breast Cancer 2015,15, e1-e11. [CrossRef]
*Amon, U.; Yaguboglu, R.; Ennis, M.; Holick, M.F.; Amon, J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of __Vitamin D__3 According to the &quot;Coimbra Protocol&quot;. Nutrients 2022,14,1575. [CrossRef]
*Finamor, D.C.; Sinigaglia-Coimbra, R.; Neves, L.C.M.; Gutierrez, M.; Silva, J.J.; Torres, L.D.; Surano, F.; Neto, D.J.; Novo, N.F.; Juliano, Y. A pilot study assessing the effect of prolonged administration of high daily doses of __Vitamin D__ on the clinical course of vitiligo and psoriasis. Derm.-Endocrinol. 2013, 5, 222-234. [CrossRef]
---
!!!!VitaminDWiki – ((Cancer)) category contains:
{include page=&quot;Cancer&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!~~#F00:87 ~~Meta-analyses  in VitaminDWiki with CANCER etc in the title
&#39;&#39;This list is automatically updated&#39;&#39;
{LIST()}
{list max=&quot;100&quot;}
{filter categories=&quot;82&quot;}
{filter field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;}
{filter type=&quot;wiki page&quot;}
{sort mode=&quot;modification_date_major_desc&quot;}
{OUTPUT(template=&quot;table&quot;)}
   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}
    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}
    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
{OUTPUT}
{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}
{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}
{LIST}
---
!!!!~~#F06:5+~~  VitaminDWiki LOADING DOSE pages with CANCER etc in title
&#39;&#39;This list is automatically updated&#39;&#39;
{LIST()}
{list max=&quot;50&quot;}
{filter categories=&quot;73&quot;}
{filter field=&quot;title&quot; content=&quot;Cancer OR  Leukemia OR lymphoma OR Melanoma  OR basal OR metastatic OR Myeloma&quot;}
{filter type=&quot;wiki page&quot;}
{sort mode=&quot;modification_date_major_desc&quot;}
{OUTPUT(template=&quot;table&quot;)}
   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n
    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}
    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
{OUTPUT}
{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}
{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}
{LIST}
---
!!!!~~#F06:726+~~  VitaminDWiki pages have both CANCER  AND VITAMIN  in the title
&#39;&#39;This list is automatically updated&#39;&#39;
&#39;&#39;__Note: This does NOT include   Leukemia,  Lymphoma, Melanoma,  etc.__&#39;&#39;
{LIST()}
  {filter type=&quot;wiki page&quot;}
  {list max=&quot;1000&quot;}
  {filter field=&quot;title&quot; content=&quot;cancer AND Vitamin&quot;}
  {filter field=&quot;title&quot; content=&quot;NOT \&quot; K2\&quot;&quot;}
  {sort mode=&quot;modification_date_major_desc&quot;}
{OUTPUT(template=&quot;table&quot;)}
   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}
    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}
    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
{OUTPUT}
{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}
{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}
{LIST}
---
!!!!600,000 Hits for (cancer metabolism) &quot;vitamin d&quot; in Google Scholar Oct 2023
__[https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C48&amp;q=%28cancer+metabolism%29+%22vitamin+d%22&amp;btnG=|Google Scholar]__
* An update on vitamin D signaling and cancer - February 2022 https://doi.org/10.1016/j.semcancer.2020.05.018  FREE PDF
 * Vitamin D and the risk for cancer: A molecular analysis - Feb 2022 https://doi.org/10.1016/j.bcp.2021.114735 FREE PDF
 * New insights into molecules and pathways of cancer metabolism and therapeutic implications - Nov 2020 https://doi.org/10.1002/cac2.12112 FREE PDF
 *Relationship Between Vitamin D Supplementation and Improvement in Body for Carcinogenesis: A Literature Review 2022 - https://doi.org/10.37275/bsm.v6i2.447 FREE PDF
* Metabolism and Colorectal Cancer - Jan 2023 https://doi.org/10.1146/annurev-pathmechdis-031521-041113 FREE PDF
</code>
</pre>

    </article>

        </div>
    </div>

    <script src="/js/lightspa.js?v=1742566338"></script>
    <script>
        
        const spa = new LightSPA({
            mainContentSelector: '[role="main"]',
            navigationSelector: '[data-spa-nav]'
        });

        
        const search = new Search({
            documentsUrl: '\/js\/search_documents.json?v=1742566338',
            indexUrl: '\/js\/search_index.json?v=1742566338'
        });
    </script>
</body>
</html>